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1 Introduction 
Cellular constituents of the mammalian central nervous system (CNS) consist of neu-
rons and glia. While neurons are known to be the principal signalling cells, glial cells 
were historically considered merely inert supportive cells. The past two decades have 
seen a dramatic evolution in this concept, and glial cells are today recognized as active 
participants in the neural circuitry.  
The multitude of neuronal and glial cell types of the mature CNS are generated from a 
homogenous pool of neural precursor cells in the embryonic neural tube, called the neu-
roepithelial precursors (NEPs). During initial embryonic developmental stages, NEPs 
display multipotency and have the ability to give rise to both neurons and glia; however 
with time their potential becomes more restricted towards either a neuronal or glial fate. 
A key question in developmental biology is whether specialised glial fate-restricted pre-
cursor cells display lineage plasticity. 
I shall now provide a brief overview to the types of glial cells in the CNS for us to ap-
preciate the diversity of these complex glial subtypes. Furthermore, I will then focus on 
the origin and development of perhaps the most intriguing glial cell type: the oligoden-
droglia. 
1.1 Glial cells of the CNS 
The major glial cell population can be divided into two sub-groups: microglia and mac-
roglia based on their developmental origin (Figure 1).  
 
Figure 1. Schematic representation of glial cells in the CNS, their interactions with neurons and 
amongst themselves. BV, Blood Vessel; OPC, Oligodendrocyte Precursor Cell. 
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Microglial cells are descendants of haemopoietic precursors and macroglial cells that 
include oligodendrocytes and astrocytes are derived from neural tube precursors. 
1.1.1 Microglia 
In 1932 Rio-Hortega described these resident macrophages of the brain parenchyma. 
Ramified or resting microglia have a crucial scavenger function in the developing brain 
by removing away large number of cells in the neocortex that die in the course of nor-
mal remodelling of the fetal brain (Voyvodic, 1996). Each individual microglial cell 
covers a large area of 50,000 µm3, never coming in contact with another microglial cell. 
Within the gray matter, microglial cells extend their processes in all directions; while 
white matter microglia align their processes perpendicular to white matter tracts.  
In the healthy brain, resting microglia have a typical ramified morphology consisting of 
a small cell body, long slender processes with secondary branching and lamellipodia. 
During CNS insult, microglial morphology changes; the ramified microglia processes 
retract, become more amoeboid-like, and transform into the reactive microglia which 
contribute to defence of the compromised system (Xiang et al., 2006). 
1.1.2 Astrocytes 
Astrocytes were discovered by Ramon y Cajal; they occupy 25% to 50% of brain vol-
ume. Their functions include regulating extracellular ion concentrations, maintaining 
the blood brain barrier and providing trophic support as well as nutrients to neurons and 
oligodendrocytes. In the adult CNS, astrocytes are uniformly distributed across the pa-
renchyma where they associate with blood vessels, the pial surface, neurons, oligoden-
drocytes and other astrocytes. Astrocytes communicate with each other via calcium sig-
nals at connexin-constituted gap junctions; they also invest neuronal cell bodies, den-
drites and synapses (Kosaka and Hama, 1986; Ventura and Harris, 1999).  
Astrocytes, like oligodendrocytes and neurons arise from embryonic precursors of the 
neural tube via radial glial cells starting from E13-E15 and continuing into late embry-
onic ages (Chan-Ling et al., 2009; Fogarty et al., 2005; Voigt, 1989; Malatesta et al., 
2003). Radial glia transformation into astrocytes also occurs postnatally in some regions 
of the rodent brain (Kriegstein and Alvarez-Buylla, 2009).  
Astrocytes display diverse morphology based on their structural and functional interac-
tions with their microenvironment. In the gray matter, astrocytes are described as proto-
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plasmic, owing to their compactness, profuse short stubby processes and a dense net-
work of lamellar side processes extending from primary processes. Astrocytes in the 
white matter have a relatively simple morphology. They are more elongated, with 50-60 
long processes extending from the cell body and oriented in parallel to axons (Miller 
and Raff, 1984). However, common features in both protoplasmic and fibrous astro-
cytes are presence of thick primary processes and the formation of processes which bear 
so-called end feet projections on blood vessels. In vitro studies also categorise astro-
cytes as type I- having a fibroblast-like morphology and being present in both white as 
well as gray matter cultures, and type II- having a neuron-like morphology and being 
present only in white matter cultures (Raff et al., 1983a). 
The astrocytic cytoskeleton is constituted by 9 nm intermediate filaments composed of a 
unique glial fibrillary acidic protein (GFAP) (Bignami et al., 1972), as well as a less 
cell-specific filament protein- vimentin (Dahl, 1981).  
1.2 The oligodendroglial lineage 
1.2.1 Oligodendrocytes 
Rapid conduction of nerve impulses is a priority for the nervous system of animals con-
stantly challenged with life and death situations. The strategy adopted by invertebrates 
for faster conduction of action potentials involved increasing the axonal diameter to 
decrease electrical resistance. For instance, the giant squid axons are upto 1 mm in di-
ameter and have rapid nerve conduction velocities. The need for a compact, powerful 
and energetically frugal nervous system in vertebrates did not allow for “axonal gigan-
tism” and therefore a major evolutionary step was wrapping axons in insulating mem-
branes of myelin sheathes: myelination (Hartline and Colman, 2007).  
Discovery of the myelinated nerve fibre is credited to Ehrenberg in 1833. Myelin en-
sheathes the axon with periodic interruptions at the Nodes of Ranvier, such that the ac-
tion potential jumps from one node to the other. Such a “saltatory” mode of impulse 
conduction greatly increases conduction velocity as well as efficiency (Bunge, 1968; 
Hirano, 1968). Disruption of myelin due to injury or pathological degeneration causes 
severe loss of neurologic functions (Fancy et al., 2011).  
Oligodendrocytes are the cellular components of the CNS responsible for the production 
of myelin.  
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The term “oligodendroglia” was coined by Rio-Hortega in 1921 to refer to neuroglial 
cells with few processes. Characteristic morphological features of oligodendrocytes 
include a high density of nucleus and cytoplasm, absence of intermediate filaments and 
of glycogen and a high number of microtubules (25 nm) in their processes, which con-
tact the axonal length (Lunn et al., 1997). Oligodendrocyte/myelin markers such as 
2’,3’-cyclic nucleotide-3’-phosphodiesterase (CNP), proteolipid protein (PLP), myelin 
associated glycoprotein (MAG), myelin/oligodendrocyte glycoprotein (MOG) and mye-
lin basic protein (MBP) have been used to study oligodendrocyte function and subse-
quent myelin defects (Baumann and Pham-Dinh, 2001). 
Progenitor cells of the oligodendroglial lineage give rise to the mature myelinating oli-
godendrocyte via an intermediate premyelinating oligodendrocyte stage (explained in 
section 1.2.3.4). The oligodendrocyte precursor cells (OPCs) are regarded as the fourth 
glial cell population of the CNS. OPCs persist within the brain throughout life, long 
after developmental myelination ceases; thereby suggesting that these cells have other 
functions in the CNS in addition to their progenitor role. OPCs arise in specialised ven-
tral domains of the spinal cord and forebrain around embryonic day (E) 12.5 (Miller, 
2002). The next section 1.2.2 is devoted to several aspects of OPC origin, development, 
morphology, physiology and fate choice. 
1.2.2 Oligodendrocyte precursor cells (OPCs) 
The immediate ancestor of the oligodendroglial cell is a precursor that in vitro has the 
ability to generate both oligodendrocytes and type-2 astrocytes, thus the name “O-2A” 
progenitor cell (Raff et al., 1983). The controversy whether during normal in vivo de-
velopment these O-2A precursor cells give rise to astrocytes, has given way to a 
more acceptable term: the “oligodendrocyte precursor cell (Noble et al., 2005; 
Richardson et al., 2011). 
Historical perspective: discovery of markers for OPCs 
The story of the oligodendroglial precursor cells began almost 35 years ago with the 
discovery of what are considered the immediate ancestor of the oligodendroglial cell- 
the “O-2A” progenitor cell, that in vitro had the ability to generate both oligodendro-
cytes and type-2 astrocytes (Raff et al., 1983). Several molecular markers such as the 
Nerve/Glial antigen- 2 or NG2 and platelet derived growth factor receptor (Pdgfrα), 
were shown to be expressed by O-2A progenitors (Stallcup and Beasley, 1987; Levine 
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and Stallcup, 1987; Richardson et al., 1988). Using these markers, the natural history of 
O-2A progenitors began to be revealed. It was shown that as these cells differentiate, 
they downregulate the expression of NG2 prior to the appearance of mature oligoden-
drocyte/myelin antigens. A small fraction of cells weakly co-express NG2 and early 
oligodendrocyte antigen galactocerebroside (GalC), implying a transition from a precur-
sor state to a mature oligodendrocyte state. 
1.2.2.1 Morphology and distribution 
Embryonic NG2 glia in the rodent CNS possess a large oval or polygonal cell body with 
one to three unbranched processes (Levine et al., 1993; Nishiyama et al., 1996), while 
postnatal OPCs are characterised by a small (10-15 µm) polygonal cell soma and a mul-
tipolar arbor of fine processes with a thickness of 0.2 to 0.5 µm (Nishiyama et al., 1996; 
Kukley et al., 2008, 2010). During development, as NG2 cells differentiate into mature 
oligodendrocytes via transitory stages, they undergo a series of morphological changes: 
an increase in the complexity of process branching, in number and length of processes, 
alongwith an increase in the total area covered by processes (Trapp et al., 1997; Kukley 
et al., 2010). Following development, OPCs in the aged CNS undergo a shortening of 
their processes and display simple arborisation (Chen et al., 2008).   
 
Figure 2. Morphological comparison between a gray matter astrocyte, OPC and a mature myelinat-
ing oligodendrocyte. A, Drawing of a gray matter astrocyte, the asterix represents a blood vessel and an 
end foot on it. B, Drawing of an NG2 cell. Note the difference between the size of the cell soma and 
thickness and size of fine processes. C, Drawing of a mature myelinating oligodendrocyte. Note the asso-
ciation with the myelin sheath. Scale bar: 10 µm applied to all (modified from Fröhlich et al., 2011). 
The morphology of NG2 cells also differs depending on their location in the brain. In 
gray matter, the cells have a centrally located soma with several long bi- or tri-furcating 
primary processes to form a symmetrical process field (Bergles et al., 2000), and on the 
other hand white matter NG2 cells have a more polarized appearance with processes 
extending along the axonal axis (Kukley et al., 2007). 
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OPCs are morphologically quite distinct from other glial cell types in the CNS (Figure 
2). Although astrocytes and NG2 glia both possess a multipolar tree of processes, NG2 
cells are quite distinct with their smaller soma, fewer and less fine secondary processes, 
finer primary processes; clearly lacking the bushy astrocytic appearance (explained in 
section 1.1.2), as well as end feet projections (Nishiyama et al., 2005). Also, in absolute 
contrast to oligodendrocytes, NG2 cells do not bear myelin sheath endings (Trapp et al., 
1997). 
The predominance of NG2+ OPCs restricted to ventral columns of the embryonic spinal 
cord and forebrain is lost during development. The peak in density of OPCs is reached 
during the first postnatal week and by this time the entire CNS becomes uniformly pop-
ulated with these cell types (Nishiyama et al., 1996).  
 
Figure 3. Distribution of OPCs in the hippocampus during postnatal development. A-C, Frontal 
sections of the rat hippocampus at (A) P7, (B) P21 and (C) P97 immunoperoxidase labelled with anti-
NG2 antibody. At P7, NG2 cells were densely distributed in non-neuronal layers, but by P97, NG2+ cells 
were uniformly distributed throughout the hippocampus (adapted from Nishiyama et al., 2002). 
 
Not all oligodendrocyte precursors differentiate during the developmental period and 
well after the early postnatal period when oligodendrocyte production is in full swing, 
OPCs persist as a uniformly distributed population in the mature CNS and make up 4 to 
9% of all cells in the adult rodent CNS (Nishiyama et al., 1999; Dawson, 2003; 
Reynolds and Hardy, 1997). While OPCs are uniformly distributed throughout the gray 
and white matter in the adult CNS, their distribution in the neuronal layer of the hippo-
campus is scarce during late embryonic and early postnatal periods (Figure 3) 
(Nishiyama et al., 2002). The persistence of OPCs long after developmental myelination 
has occurred, raises exciting prospects about their role in myelin repair, giving rise to 
other cell types in the adult brain and synaptic signalling. 
1.2.2.2 Physiology 
Ion channels 
OPCs in gray and white matter express a wide range of voltage-gated channels that lead 
to active membrane properties. Depolarising voltage steps from the resting potential 
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elicit both rapidly inactivating as well as sustained outward K+ currents (Chittajallu et 
al., 2004; Kukley et al., 2010). In addition to outward K+ currents, NG2 cells have also 
been shown to exhibit inward K+ currents to a variable degree (Lin and Bergles, 2003). 
It has been speculated that expression of potassium channels by OPCs has a role to play 
in their proliferation (Gallo et al., 2008). OPCs in the gray and white matters of the de-
veloping brain have also been shown to express voltage-gated sodium channels, al-
though there is a disagreement on the proportion of NG2 cells expressing Na+ channels 
(Fröhlich et al., 2011). It has also been demonstrated that Ca++ influx into the NG2 cells 
is mediated by Na+ channels through Na+/Ca++ exchangers (Tong et al., 2009).  
Neuron-OPC synapse 
Electrophysiological studies revealed that gray matter and white matter NG2+ OPCs 
have been shown to express alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic 
acid (AMPA)/kainate and/or gamma-amino butyric acid (GABA) neurotransmitter re-
ceptors (Bergles et al., 2010). The expression of voltage-gated channels and neuro-
transmitter receptors by OPCs provided the first clues about their communication with 
neighbouring neurons. Evidence of a novel neuron-NG2 cell synapse was shown by 
generation of AMPA receptor-mediated fast excitatory postsynaptic currents (EPSCs) in 
OPCs of the hippocampal CA1 region in response to schaffer collateral stimulation 
(Bergles et al., 2000; Jabs et al., 2005). Since then, neuron-OPC synapses have been 
widely reported in the cerebellum (Lin et al., 2005), cortex (Chittajallu et al., 2004) and 
corpus callosum (Kukley et al., 2007; Ziskin et al., 2007). It has been shown in the cer-
ebellum and white matter that single NG2 cells form hundreds of synaptic contacts (Lin 
et al., 2005; Kukley et al., 2007; Ziskin et al., 2007). 
The two major neurotransmitters- glutamate and GABA mediate synaptic transmission 
onto OPCs (Kukley et al., 2007, 2008; Ziskin et al., 2007). In the absence of any neu-
ronal targets, the mechanism of glutamate transmitter release onto OPCs has been 
shown to consist of dedicated molecular machinery reminiscent of neuron-neuron syn-
aptic transmission. Glutamate release from a pool of readily releasable vesicles follow-
ing highly synchronous fusion events is triggered by Ca++ microdomains in the axons. 
This quantal transmission on OPCs results in inward currents in them, termed as axo-
glial currents (Kukley et al., 2007).  
The irrelevance of N-methyl-D-aspartate (NMDA) receptor signalling for oligodendro-
glial development and myelination (De Biase et al., 2011; Guo et al., 2012), alongwith 
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the minimal expression of kainate receptors in OPCs (Kukley and Dietrich, 2009) sug-
gests that the AMPA receptor is the key mediator of neuron-OPC synaptic signalling. 
Finally it has been suggested that synaptic glutamate release might induce Ca++ eleva-
tion in OPCs via Ca++ permeable AMPA receptors (Ge et al., 2006).  
It is therefore tempting to speculate that glutamate receptor mediated axo-glial currents 
in OPCs as a result of ongoing neuronal activity could serve as a cue to trigger several 
calcium dependent signalling cascades that could influence OPC physiology in vivo. 
Culture studies in the past have shown that glutamate-mediated activation of AMPA 
receptors inhibits proliferation and differentiation of OPCs, as well as stimulates their 
migration (Gallo et al., 1996; Yuan et al., 1998; Gudz et al., 2006). Downregulation of 
glutamate input onto differentiating oligodendroglial cells could also serve to influence 
the maturation of these cell types (Kukley et al., 2010). 
AMPA receptors are channel tetramers which are assembled from a group of four sub-
units: GluR1-4 or GluRA-D, which are encoded by four different genes (Greger et al., 
2007; Verkhratsky and Steinhäuser, 2000). 
 
 
Figure 4. Expression of the GluRB subunit in OPCs. A-B, Illustration of the subunit composition of 
the glutamate receptor. Presence of the GluRB subunit renders the receptor calcium impermeable (A) and 
in the absence of the GluRB subunit, the receptor is calcium permeable (B).  
The calcium permeability of the AMPA receptor depends critically on its subunit com-
position and the GluRB subunit is particularly important in this regard. In the presence 
of the GluRB subunit the receptor is Ca++ impermeable, while in its absence Ca++ influx 
can occur through the receptor (as shown in Figure 4). Ectopic expression studies re-
vealed that the GluR heteromer is Ca++ impermeable due to the presence of an RNA 
editing site at the GluRB subunit (Burnashev et al., 1992; Hume et al., 1991).  
OPCs in the postnatal brain during ongoing oligodendrogliogenesis and in culture have 
been shown to contain the GluRB subunit (Matthias et al., 2003; Kukley et al., 2007; 
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Stegmüller et al., 2003), whereas in the adult brain when the process of myelination is 
nearly completed, it has been reported that glutamate receptors in OPCs do not contain 
the GluRB subunit (Ziskin et al., 2007). This switch in subunit composition may indi-
cate a particular importance of GluRB during the developmental period.  
For this reason as well as for the pivotal role of this subunit in regulating calcium per-
meability, I chose to focus my interest on the role of the GluRB subunit in the develop-
ment of OPCs by performing a loss of function analysis. 
1.2.2.3 Cell cycle dynamics 
OPCs represent the major cycling cell population in the adult mammalian brain paren-
chyma. Studies using 5-bromo-2-deoxyuridine (BrdU) labelling indicate that they com-
prise nearly 70% of all proliferating BrdU positive cells in the hippocampus, cerebral 
cortex, spinal cord and corpus callosum (Horner et al., 2000; Dawson, 2003; Polito and 
Reynolds, 2005; Bu et al., 2004). The proportion of actively cycling OPCs amongst the 
entire OPC cell population, also known as the growth fraction, is high in young (~2 
weeks old) as well as in adult (~18-20 months) animals. Using proliferating cell nuclear 
antigen (PCNA) and BrdU labelling, the growth fraction of NG2 cells at early postnatal 
ages was estimated to be ~50% in the hippocampus, corpus callosum and cerebral cor-
tex (Kukley et al., 2008; Psachoulia et al., 2009).  
At adult ages the OPC growth fraction was also reported invariantly to be ~50% in both 
cortex and corpus callosum (Rivers et al., 2008; Psachoulia et al., 2009). This would 
imply that at any given time in both gray and white matter regions almost half of the 
OPC population is mitotically inactive. However, the existence of two separate dividing 
and non-dividing subpopulations of NG2 cells in CNS has been contested by recent 
studies which indicate that all NG2 cells regardless of region are dividing (Kang et al., 
2010; Clarke et al., 2012). Interestingly, the decrease in rate of oligodendrocyte produc-
tion from OPCs follows a close parallel with increase in cell cycle time of NG2 cells 
over development (Psachoulia et al., 2009). 
1.2.2.4 Fate choice 
Extensive cell culture studies have shown that OPCs can be induced to differentiate into 
type-2 astrocytes upon the application of fetal calf serum (FCS) (Raff et al., 1983) and 
certain cytokines, including the bone morphogenic protein (BMP) (Mabie et al., 1997).  
In a series of elegant experiments, Kondo and Raff (2000) showed that these type-2 
1 Introduction 15 
astrocytes, generated by treatment of NG2 glia purified from postnatal day 6 rat optic 
nerve with FCS or BMP; could be re-programmed into multipotent CNS stem cells. 
These reverted cells had the capacity to self-renew, give rise to neurons, type-1 astro-
cytes and oligodendrocytes. Transplantation studies suggest NG2 cells represent the 
“type C” cells in the SVZ (Aguirre and Gallo, 2004), with a neurogenic potential in cul-
ture (Belachew et al., 2003) and upon transplantation (Aguirre et al., 2004).  
Extensive in vivo studies utilising Cre-lox approach have also been used to elucidate 
OPC lineage. 
Oligodendroglial Fate 
Efforts to study the oligodendroglial progression of OPCs in vivo has been challenging 
since NG2 expression is lost during terminal differentiation of the precursor and ap-
pearance of mature oligodendroglial antigens. Pulse chase labelling of proliferating cells 
using BrdU revealed a decrease in the number of BrdU+NG2+ cells that followed in 
parallel an increase of BrdU+ oligodendrocytes over time (Polito and Reynolds, 2005), 
providing an indirect evidence of generation of oligodendrocytes from OPCs.  
Direct evidence was required to solve the “conundrum” of the differentiation fates of 
OPCs and the breakthrough came with the use of Cre-lox fate mapping of OPCs in 
transgenic mice. Using constitutive Cre expression in NG2creBAC transgenic mice and 
inducible Cre expression in NG2creERTMBAC mice to label the progeny of NG2 glia, a 
large number of myelinating oligodendrocytes were found among GFP-labelled progeny 
of OPCs (Zhu et al., 2008a, 2008b, 2011). Subsequently several other mouse lines were 
used to study the fate of NG2 cells in perinatal and adult ages - PdgfrαcreERTM (Rivers 
et al., 2008; Kang et al., 2010), Olig2creERTM (Dimou et al., 2008; Ono et al., 2008), 
PlpcreERTM (Guo et al., 2009, 2010) all establishing the oligodendroglial fate of NG2 
expressing cells. Apart from their oligodendroglial potential in the normal brain, fate 
mapping studies have also demonstrated that OPCs rise to oligodendrocytes during the 
process of remyelination, following a demyelinating insult (Zawadzka et al., 2010; 
Kang et al., 2010). 
Astrocytic Fate 
Failure to detect co-expression of GFAP and NG2 antigens in cell types in the CNS 
(Nishiyama et al., 2002), gave way to the view that generation of astrocytes from O-2A 
progenitors was merely a culture artefact and that OPCs and astrocytes were not lineally 
related. 
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Direct in-vivo of OPCs utilising Cre expression under the NG2 promoter reveal a sig-
nificant population of GFP labelled protoplasmic astrocytes in the gray matter ventral 
forebrain region and spinal cord (Zhu et al., 2008a, 2008b). A follow-up study by the 
same group provided evidence that OPCs generate astrocytes only during embryonic 
CNS development (Zhu et al., 2011). The astrogliogenic fate of OPCs being restricted 
to the embryonic phase was inconsistent with other studies employing inducible Cre 
expression under Olig2 and Plp promoters, in which reporter positive astrocytes were 
found upon postnatal Cre induction (Dimou et al., 2008; Guo et al., 2009, 2010).  
In contrast to these observations, two separate studies with different Pdgfrα constructs 
used to drive inducible Cre expression in OPCs with TMX administration at postnatal 
ages (P30 and P45), do not report EGFP or EYFP labelling in astrocytes (Rivers et al., 
2008; Kang et al., 2010). It has been postulated that the appearance of reporter positive 
white matter astrocytes in the Olig2creERTM line is due to Olig2 expression in cells of 
the germinal zones and that these astrocytes may not be progeny OPCs (Ligon et al., 
2006). Nevertheless, astrocytic differentiation from NG2 cells has also been reported in 
traumatic brain injury and experimental pathology models (Alonso, 2005; Tripathi et 
al., 2010).  
Neuronal Fate 
In vivo studies using the Cre-lox system undertaken to elucidate the neuronal fate of 
OPCs, have not been successful in providing an unequivocal answer to this question. 
Adult P45 TMX induction in PdgfrαcreERTM mice to label NG2 glia reveal EYFP-
labelled progeny of OPCs that co-label NeuN, and resemble projection neurons in the 
anterior piriform cortex. Upon BrdU labelling, no reporter positive neurons were found 
to be BrdU positive, suggesting that these neurons were formed by direct transformation 
of long term quiescent NG2 cell population (Rivers et al., 2008). In PlpcreERTM, early 
postnatal NG2 cells (P7 Cre induction) were shown to generate few pyramidal neurons 
in the cerebral cortex and hippocampal interneurons (Guo et al., 2009, 2010).  
However, other transgenic approaches have failed to arrive at a consensus vis-à-vis the 
neurogenic potential of OPCs. For example, also using PdgfrαcreERTM mice Kang et al. 
(2010) did not observe any long term surviving EGFP labelled neurons in the forebrain 
upon P30 Cre induction, as was the case with the NG2creBAC transgenic study (Zhu et 
al., 2008a) and Olig2creERTM mice (Dimou et al., 2008). However, GABAergic neu-
rons have been reported to be progeny of early embryonic Olig2+ cells (Ono et al., 
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2008) and groups have alluded to cases of reporter positivity in small number of NeuN 
positive neurons throughout the forebrain, particularly in the ventral regions following 
short times after Cre induction (Zhu et al., 2011; Kang et al., 2010; Dimou et al., 2008). 
Phenotypic analysis of the progeny of adult SVZ NG2 cells, also refute claims of the 
neurogenic potential of OPCs (Komitova et al., 2009). 
While it is safe to say that the oligodendroglial potential of NG2-expressing OPCs has 
been well established, further experiments are needed to resolve the ambiguity of the 
astrocytic and neuronal fate choice of these cells and the local signals as well as envi-
ronmental cues that control these differing fates. 
1.2.3 Oligodendroglial development 
1.2.3.1 Origin of OPCs 
In the embryonic spinal cord where the scheme of oligodendroglial development is rela-
tively simple as compared to the forebrain, the first committed cells of the oligodendro-
glial lineage arise in a column of the ventral ventricular zone. This ventricular zone col-
umn also generates motor neurons and is known as the progenitor motor neuron domain 
or the pMN domain (Jessell, 2000). Pringle et al. (1996) have suggested the existence of 
a common precursor for both oligodendrocytes and motor neurons known as the motor 
neuron/oligodendrocyte precursor cell or MNOP cell. In apparent contrast to lineage 
association between oligodendrocytes and motor neurons, studies indicate that OPCs 
develop from an immature cell restricted to give rise to only glial progeny (Rao et al., 
1998). This tripotential glia restricted precursor (GRP) is restricted to the generation of 
oligodendrocytes, type-1 astrocytes and type-2 astrocytes. GRP cells do not give rise to 
neurons, which as per this hypothesis are generated from neuron restricted precursors 
(Miller, 2002). In light of the observed heterogeneity amongst oligodendroglial popula-
tions, a probable model consisting of both the GRP and MNOP cell pools of oligoden-
drocyte ancestory can be imagined to exist during oligodendroglial specification. 
1.2.3.2 Multiple waves of oligodendrocyte production 
Progenitor motor neuron (pMN) precursor cells complete motor neuron formation by 
E10.5 in mice, and this is followed by a phase of oligodendrocyte production. Activa-
tion of the basic helix loop helix (bHLH) transcription factors Olig1 and Olig2 through 
the sonic hedgehog (Shh) signalling is essential for both motor neuron and oligodendro-
cyte development (Lu et al., 2002).  
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OPCs arise in three distinct waves from different regions of the spinal cord (see Figure 
5). In the first wave, OPCs arise ventrally from Olig2- expressing progenitor cells in the 
pMN domain at E12.5 and subsequently migrate to populate the entire neural tube. The 
development of these cells depends on Shh-mediated signalling, which serves as a “ven-
tralizing” signal and its balance with the dorsally derived bone morphogenic proteins 
(BMPs) and molecules of the Wnt pathway are critical determinants of oligodendroglial 
specification. At later fetal stages ~E15.5, the second wave of OPCs emerges from dor-
sal sources in an Shh-independent manner (Cai et al., 2005; Vallstedt et al., 2005). The 
third and last wave occurs after birth. OPCs from ventral and dorsal regions are inter-
mixed in the spinal cord, with a predominance of pMN-derived cells (Rowitch and 
Kriegstein, 2010).  
 
Figure 5. Illustration of generation of oligodendrocyte precursor cells (OPCs) in three distinct se-
quential waves in the mammalian CNS. A, Two sequential waves of OPCs: OPC1 and OPC2 arise 
from the ventral and dorsal regions of the Spinal Cord respectively. The third wave, OPC3 occurs after 
birth but its origin remains unclear. B, Similarly, three sequential waves of OPCs: OPC1, OPC2 and 
OPC3 arise in the telencephalon. OPC arise from Nkx2.1-expressing MGE precursors at E12.5; OPC2 
from Gsh2-expressing LGE-CGE precursors at E15.5 and Emx1-expressing cortical precursors comprise 
the OPC3 wave at P0 (adapted from Kessaris et al., 2006). 
The ventral foci of OPCs in the neural tube express Pdgfrα beginning E13-E14 (Pringle 
and Richardson, 1993) and mRNA for the myelin genes: 2’,3’ -cyclic nucleotide 3’ –
phosphodiesterase (CNP) and the DM-20 isoform of the proteolipid protein (PLP) from 
E12 onwards (Yu et al., 1994; Timsit et al., 1995).  
Within a day or two after their appearance in the spinal cord ventricular zone (VZ), the-
se Pdgfrα+ cells expand by local proliferation and eventually occupy the entire paren-
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chyma at birth (Pringle and Richardson, 1993). NG2 expression by the Pdgfrα+ OPCs is 
acquired outside of the VZ around E15-E16 (Nishiyama et al., 1996). 
An analogous, if not more complex, scheme of oligodendroglial development exists in 
the forebrain. Cre-lox fate mapping experiments have demonstrated multiple waves of 
OPC production from embryonic to postnatal ages emerging in a ventral-to-dorsal pro-
gression and populating the entire telencephalon- corpus callosum, motor cortex, lateral 
olfactory cortex, anterior commissure and preoptic area. The earliest cortical oligoden-
drocytes arise from Nkx2.1-expressing precursor cells originating in ventricular zone 
(VZ) of the medial ganglionic eminence (MGE) and the anterior entopeduncular area 
(AEP) starting E12.5, migrating to the entire telencephalon (both dorsal and ventral) 
and populating the cerebral cortex by E16. The second and the third populations of 
OPCs arise from Gsh2-expressing precursors in the lateral and caudal ganglionic emi-
nence (LGE, CGE) at E16 and Emx1-expressing precursors in the postnatal dorsal and 
ventral cortex. Paradoxically, most of the early born OPCs disappear after birth, such 
that majority of oligodendrocytes in the adult dorsal cortex are derived from the Emx1-
expressing precursors (Kessaris et al., 2006).  
In the postnatal CNS and during adulthood, the subventricular zone (SVZ) plays an im-
portant role in the generation of OPCs. Retroviral studies show that NG2 cells in the 
corpus callosum and neocortex are generated from the neonatal SVZ (Levison et al., 
1999). GFAP+ SVZ type B cells have also been identified as progenitors of oligoden-
drocytes in the adult CNS (Menn et al., 2006).  
Cre-lox fate mapping studies using radial glial specific promoters show that radial glial 
cells go through OPC stages to generate oligodendrocytes throughout development 
(Fogarty et al., 2005; Casper and McCarthy, 2006). 
1.2.3.3 OPC migration and proliferation 
The origin of OPCs during early embryonic forebrain development has been shown to 
occur at highly restricted ventral foci from Nkx 2.1 and Gsh 2 expressing precursors 
(section 1.2.3.2). From their sites of origin, OPCs migrate through the developing fore-
brain to their final destinations in the gray and white matter regions. In more rostral re-
gions of the CNS, OPCs have been shown to migrate from the MGE and LGE to the 
developing forebrain (Spassky et al., 1998). The migration of oligodendrocyte precur-
sors throughout the developing CNS has been shown to be mediated by specific direc-
tional and substrate cues like netrins and semaphorins (Sugimoto et al., 2001). Evidence 
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for the dorsal to ventral migration of OPCs has also been shown in the spinal cord by 
cell tracing experiments (Warf et al., 1991).  
Following commitment in the ventricular zone, OPCs undergo extensive proliferation 
and reach their maximum density during the first postnatal week. The early phases of 
this proliferation occur in the VZ and SVZ while the majority of oligodendrocyte pre-
cursor proliferation occurs after migration to the developing white matter (Miller, 
2002). BrdU incorporation assay in the P5-P6 corpus callosum reveal that nearly 50% 
of OPCs were BrdU+ (Psachoulia et al., 2009). In the ventral spinal cord 40% of oli-
godendroglial precursors were BrdU+ between P3-P4 and 1 day later, this fraction in-
creased to 50% (Miller et al., 1997). During this developmental period it has also been 
shown that minimal proliferation of glial precursors occurs in the VZ and SVZ (Hardy 
and Reynolds, 1991; Miller et al., 1997).  
1.2.3.4 Oligodendroglial maturation: cellular markers 
Co-expression of NG2 and mature oligodendrocyte antigens in a subset of cells indi-
cated a transitory phase in OPC lineage progression. As they migrate from their sites of 
origin, OPCs settle along future white matter tracts or gray matter regions and transform 
into an intermediate, post-migratory pre-oligodendrocyte stage recognized by O4 im-
munoreactivity (Bansal and Pfeiffer, 1992). A schematic illustration of the different 
stages of OPC development into a mature myelinating oligodendrocyte is shown in Fig-
ure 6. 
Premyelinating oligodendrocyte: The next step in oligodendroglial maturation is rep-
resented by a transient stage- the premyelinating oligodendrocyte stage. Studies with 
retroviral markers (Levison and Goldman, 1993) and immunohistochemistry (Hardy 
and Reynolds, 1991) have identified immature or premyelinating oligodendrocytes dur-
ing development of the rodent brain.  
DM20- an alternatively spliced product of the PLP gene has been detected in the devel-
oping brain before the appearance of myelin (Timsit et al., 1995) and is an established 
marker for premyelinating oligodendrocytes. The fact that these premyelinating oli-
godendrocytes originate from NG2+ precursors is demonstrated by cells that co-express 
both the NG2 and DM20/PLP antigens.  
Premyelinating oligodendrocytes with DM20+ multiple-overlapping process arborisa-
tions have been shown to occupy 80 µm domain in cortex and 40 µm domains in the 
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corpus callosum (Trapp et al., 1997). Premyelinating oligodendrocytes differ in mor-
phology as compared to OPCs in having a larger total process length, area covered by 
processes and soma diameter (Kukley et al., 2010).  
Myelinating oligodendrocyte: Premyelinating oligodendrocytes either differentiate 
into mature myelinating oligodendrocytes upon axonal contact or undergo degeneration 
(Trapp et al., 1997). The majority of myelinating oligodendrocytes have appeared in the 
mouse brain by four weeks after birth, with peak myelinogenesis occurring around the 
second postnatal week (Miller, 2002; Sturrock, 1980). Fully differentiated oligodendro-
cytes express markers such as CNP, MBP, PLP and MOG to name a few.  
Figure 6. Schematic representation of oligodendrocyte development. NG2 and PDGFRα are not ex-
pressed by OLIG2 positive neural stem cells, but are expressed by proliferating OPCs derived from them. 
Proliferation is depicted by circular arrows. Next, OPCs differentiate into DM-20 positive premyelinating 
oligodendrocytes and cease to express the NG2 and PDGFRα antigens. Terminal differentiation into the 
mature myelinating oligodendrocyte state initiates expression of PLP, MBP and CNP myelin proteins. 
OPC, oligodendrocyte precursor cell; PDGFRα, platelet derived growth factor alpha; PLP, proteolipid 
protein; MBP, myelin basic protein; CNP, 2’,3’ -cyclic nucleotide 3’ –phosphodiesterase. 
The mature oligodendrocyte/myelin marker- CNP and its utility in my study is ex-
plained in great detail in the following section. 
1.2.4 2´,3´ -Cyclic Nucleotide 3´ -Phosphodiesterase (CNP)  
Drummond et al. (1962) provided the first evidence of an enzymatic activity in the brain 
that hydrolyses 2´,3´–cyclic nucleotides exclusively to nucleoside 2´ –phosphates. In the 
five decades following the discovery of these unusual phosphodiesterases, innumerable 
studies have been undertaken to characterise and purify CNP, as well as to elucidate its 
localization, physiological activity and functional significance. 
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Gene structure 
The gene encoding for CNP is located on chromosome 17 in humans and chromosomes 
11 and 3 in mice (Sprinkle et al., 1992; Douglas et al., 1992; Bernier et al., 1988). The 
second CNP locus on the mouse chromosome 3 is considered dysfunctional (Braun et 
al., 2004). It has been demonstrated that the 6 to 9 kb long CNP gene, consisting of four 
exons and three introns (Monoh et al., 1989, 1993), encodes two known CNP isoforms: 
CNP1 and CNP2. The larger 48 kDa CNP2 protein is identical to the 46 kDa CNP1 ex-
cept for an additional 20 amino acids at its amino terminus. The transcripts encoding 
these two separate isoforms differ at their 5´ ends and are under the control of separate 
promoter regions, a 2.6 kb transcript encodes CNP1, while a 2.4 kb transcript encodes 
CNP2. The CNP1 mRNA is transcribed from the proximal promoter located between 
the first two exons, and contains only the open reading frame of the CNP1 isoform 
(Figure 7).  
Figure 7. Schematic structure of the 5’ end of mouse CNP gene and the resulting primary tran-
scripts. A, The first two exons with the distal (P2) and proximal (P1) promoters are depicted. CNP1 
mRNA is generated from P1 whereas transcription from P2, followed by an additional splicing event 
within the non-coding region of exon 1 gives rise to the CNP2 mRNA. B, Sequence of the bi-functional 
CNP2 mRNA surrounding the two in-frame initiation sites of AUG. Translational initiation at the first 
and second AUG generates CNP2 and CNP1 polypeptides respectively (adapted from Braun et al., 2004). 
Transcription of the CNP2 mRNA is initiated 1 kb upstream at the distal promoter. The 
primary transcript originating from the distal promoter undergoes an additional splicing 
event to fuse sequences encoded by an upstream exon, including an AUG sequence and 
additional 60 base pairs of coding sequence, to sequences just upstream of the AUG of 
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the smaller protein, adding 20 amino acids (Kurihara et al., 1990; Gravel et al., 1994; 
O’Neill et al., 1997). Therefore, the CNP2 transcript has two AUG start and stop codons 
in frame, from the first and second exons and can thus give rise to both CNP isoforms.  
This however does not preclude the fact that the two CNP isoforms are encoded by sep-
arate mRNAs that have been transcribed from two separate promoters located within the 
single CNP gene. Both polypeptides are synthesized on free ribosomes (Gillespie et al., 
1990), are enzymatically active and are post-translationally modified by isoprenylation 
at the C-terminus (De Angelis and Braun, 1994, 1996; O’Neill and Braun, 2000). 
1.2.4.1 CNP expression in the oligodendroglial lineage 
CNPase is most prominent in the CNS and comprises 4% of the total myelin protein. 
Several studies report the close association of the CNPase protein with myelin sheaths 
(Kurihara and Tsukada, 1967; Kurihara and Tsukada, 1968; Drummond et al., 1962). In 
vivo and in culture, CNPase is expressed as early as GalC, which is considered to be a 
very early marker for differentiating oligodendrocytes (Brenner et al., 1986; Reynolds 
and Wilkin, 1988). The protein appears early in development, preceding myelination 
and is then maintained at high levels as myelin is produced (Snyder et al., 1983; 
Sprinkle et al., 1978). Although high levels of CNP are found to accumulate in differen-
tiating and myelinating oligodendrocytes in parallel with the major structural myelin 
proteins: MBP and PLP, the onset of its expression occurs much earlier. In rat, CNP 
expression peaks around postnatal day 10, at a time when OPCs enter the phase of ter-
minal differentiation (Amur-Umarjee et al., 1990; Bansal and Pfeiffer, 1985). 
Immunohistochemical and in situ hybridisation studies indicate that CNP is concen-
trated within specific regions of the oligodendrocyte cell bodies, processes and myelin 
internodes (Nishizawa et al., 1981; Brenner et al., 1986; Reynolds and Wilkin, 1988; 
Trapp et al., 1988; Vogel and Thompson, 1988). Abundant CNP is visualised in the 
myriad filopodia of premyelinating oligodendrocytes, and upon their differentiation to 
mature oligodendrocytes, the protein is expressed in large processes that terminate on 
the myelin internode. Isoprenylation and Palmitoylation at the C-terminus mediate bind-
ing of CNP to membranes (Braun et al., 1991; De Angelis and Braun, 1994).  
At the mRNA level, in vitro, the CNP2 -2.4 kb transcript was present specifically in O-
2A progenitor cells, while the CNP1 mRNA was detected only in differentiating oli-
godendrocytes. In situ hybridisation studies in the developing ventral spinal cord of rat 
demonstrated that CNP expression regressed from being uniformly distributed at E12 to 
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a columnar cell population co-expressing Pdgfrα at E14, reinforcing its expression in 
precursor cells. The absence of co-localization of CNP and OPC-specific DM-20 tran-
scripts was suggestive of the existence of two separate subsets of progenitor cells in the 
spinal cord (Yu et al., 1994). However, other studies reported patterns of expression of 
CNP transcripts being superimposable on that of DM-20, starting from E12.5 in the 
diencephalon and E14.5 in the rhombencephalon, postulating that these two mRNAs 
were expressed in the same cell (Peyron et al., 1997). Therefore, there seem to exist two 
different patterns of CNP expression in the spinal cord and brain. In CNP-lacZ trans-
genic mice where LacZ reporter gene is coupled with a 4 kb mouse CNP gene, trans-
gene expression is detected in embryonic brain and spinal cord in immature oligoden-
drocytes and postnatally in the white matter (Gravel et al., 1998). While the above in 
situ studies employed full length CNP cDNA that did not discriminate between the two 
isoforms, the expression of CNP1 and CNP2 mRNA and protein has also been eluci-
dated. Northern blot analysis revealed that the CNP1 mRNA is expressed by the brain 
and sciatic nerve, where as a 2.4-2.5 kb transcript similar to CNP2 is expressed addi-
tionally in the thymus and testes, indicative of the activity of the distal promoter in non-
myelinating cells. The CNP2 mRNA can be detected embryonically as opposed to the 
postnatal expression of CNP1 mRNA. The CNP2 transcript and protein is expressed by 
oligodendrocyte precursors early in brain development, before the onset of myelination 
and eventually both protein isoforms accumulate during myelination in parallel with 
other myelin proteins (Scherer et al., 1994). 
In addition to its expression in the CNS, Schwann cells in the peripheral nervous system 
(PNS) also express high amounts of CNPase (Sprinkle, 1989). Nonmyelin CNP is also 
shown to be expressed in vertebrate erythrocytes (Weissbarth et al., 1981), lymphocytes 
and platelets (Rastogi and Clausen, 1985; Sheedlo et al., 1984; Sprinkle et al., 1985), 
thymus (Bernier et al., 1987), liver (Dreiling et al., 1981) and photoreceptor cells of the 
retina (Giulian and Moore, 1980; Nishizawa et al., 1982). More recently, CNP has been 
reported in Leydig and Sertoli cells of the testis (Davidoff et al., 1997, 2002). 
Functional Significance of the CNPase enzyme 
CNP enzyme catalyses cleavage of the phosphodiester bond and exclusive production of 
2´ -nucleotide phosphates from 2´,3´ -cyclic mono-nucleotides in vitro (Drummond et 
al.,1962; Sprinkle et al., 1978). The enzymatic activity was first demonstrated in bovine 
spleen and pancreas (Whitfeld et al., 1955; Allen and Davis, 1956).  
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Although the physiologically relevant substrates, 2´,3´ -cyclic nucleotides are not pre-
sent in the brain, numerous cyclic phosphate-containing RNAs which occur as interme-
diates of RNA metabolism, suggest that CNPase may serve other functions than its en-
zymatic potential (Heaton and Eckstein, 1996). The association of CNP with myelin and 
its expression patterns in the OPCs (at the mRNA level) and differentiated oligodendro-
cytes suggests a crucial role for CNP in the process of myelination. CNP also governs 
co-ordinated cytoskeletal reorganisations during process formation and outgrowth in 
oligodendrocytes (Lee et al., 2005). Association of CNP with microtubules (MTs) and 
its MT polymerization activity classifies CNP as a microtubule-associated protein 
(MAP) (Dyer and Benjamins, 1989; Laezza et al., 1997; Bifulco et al., 2002). In mice 
over-expressing CNP, premyelinating oligodendrocytes extend redundant membranous 
process extensions and adult oligodendrocytes from these transgenic animals re-grow 
dramatically large processes in culture (Gravel et al., 1996; Yin et al., 1997). Interest-
ingly, ectopic CNP expression in fibroblasts induces formation of filopodia and proc-
esses (De Angelis and Braun, 1994). On the other hand, in CNP-null mice the ultra-
structure and periodicity of myelin and myelin assembly is not affected but adult mice 
experience a severe neurodegeneration causing a large microglial response, hydrocepha-
lus and premature death. This is indicative that CNP clearly has a role in axonal survival 
(Lappe-Siefke et al., 2003). Furthermore, CNP deficiency also caused lapses in the par-
anodal loop structures of oligodendrocytes and failure to form proper axo-glial contacts 
at the paranodes directly leads to aberrant axo-glial signalling, resulting in axonal death 
or loss (Rasband et al., 2005; Salzer, 2003). Recently, the discovery of ATP/GTP bind-
ing sites on CNP indicate that it may be involved in signal transduction pathways 
(Stingo et al., 2007). CNP has also been shown to be an RNA-binding protein and a 
regulator of RNA function, processing and degradation (Gravel et al., 2009).  
1.2.4.2 Selection of Cnp-dependent Cre driver line 
Amongst the plenitude of oligodendroglial lineage-specific genes used in in vivo lineage 
studies of OPCs, the oligodendroglial lineage marker of interest in my study is 2’,3’ -
cyclic nucleotide 3’ –phosphodiesterase (CNP), which is detectable in all cells of the 
oligodendroglial lineage (Yu et al., 1994) and is maintained in mature oligodendrocytes 
throughout life.  
The Cnp gene product- CNPase is expressed only in mature myelinating oligodendro-
cytes. Therefore, only relatively differentiated OPCs- those that had perhaps already 
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made the decision to mature into the oligodendroglial state will change their gene ex-
pression profile to initiate activity of the Cnp promoter. These OPCs in which the Cnp 
promoter is active do not express the CNPase protein yet, which will only be expressed 
upon terminal differentiation to the oligodendrocyte. 
In my study, I chose to utilise a Cnp promoter driven Cre-lox approach to focus specifi-
cally on a later or advanced time point during the development of the OPC. I consider 
this subset of OPCs labelled by CNP-Cre mediated recombination, relatively differenti-
ated as compared to their early stage counterparts and term these as “late OPCs”. These 
are OPCs that have perhaps already made the decision to differentiate into mature oli-
godendrocytes and will start expression of the Cnp promoter, unlike their more imma-
ture counterparts or the “early OPCs”.   
1.3 Neurogenesis 
An important question in the field of oligodendroglial biology is whether OPCs gener-
ate neurons, and therefore now I will give a brief overview into the process of neuro-
genesis in the CNS. 
Neurogenesis or the birth of neurons is the process by which neurons are generated. 
Most active during embryonic development, neurogenesis which is responsible for pop-
ulating the growing brain continues well into adulthood. There exist three distinct sets 
of progenitor cell pools in the embryonic telencephalon: neuroepithelial cells, radial glia 
and intermediate or basal progenitors (Figure 8). Since the neuroepithelial cells are the 
only cells present in the neural tube at early stages, it implies that they generate directly 
or indirectly, through progression to radial glia and basal progenitors, to all the neurons 
and glial cells of the adult CNS. 
1.3.1 Embryonic neurogenesis 
The basic terminology and events of the developing CNS were formulated almost 80 
years ago by His, describing the idea that germinal cells divide at the ventricular surface 
of the CNS, giving rise to postmitotic neuroblasts that move outward to form a mantle 
layer. This historical terminology was modified as per rules of the Boulder Committee 
in 1969 to propose that the embryonic CNS consists of four fundamental zones from 
which the adult organisation is derived: the ventricular zone, the subventricular zone, 
the intermediate zone and the marginal zone (Angevine et al.,1970). 
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During early development, there is a dramatic surge in the neuroepithelial cells in the 
dorsolateral wall of the rostral neural tube. At the ventricular zone (VZ), the neural pro-
genitor cells undergo characteristic interkinetic nuclear migration: alternate movement 
of the nucleus between the basal and apical surface (Sauer, 1935). This migration is 
synchronised with respect to the cell cycle, with the nucleus being at the apical surface 
during mitosis, moving towards the basal surface through G1 and the S phase at the 
most basal location and then migrating back apically through G2. Since at any given 
time the progenitor cells are not synchronised, with different cells being in various 
phases of the cell cycle, this gives a pseudostratified appearance.  
The pseudostartified neuroepithelial cells undergo symmetric cell divisions to expand 
the pool of multipotent progenitors and around E10.5 the earliest born neurons arise 
from asymmetric divisions to form the layered preplate. The preplate splits into the su-
perficial marginal zone and the deep seated subplate, and the cortical plate which will 
later give rise to the neocortex, begins to develop between these two layers. 
Neurons populate the cortex in an “inside-out” manner, with the earliest born neurons 
settling into deeper laminae and later born neurons migrating past them to occupy more 
superficial layers (Angevine and Sidman, 1961; Bayer and Altman, 1991; McConnell 
and Kaznowski, 1991). Shortly after the appearance of the first neurons, neuroepithelial 
cells give rise to radial glial cells around E11, which in addition to serving as a scaffold 
for neuronal migration, also have a neuronogenic potential. Radial glial cells maintain a 
shape similar to neuroepithelial cells, with a long basal process extending upto the pial 
surface and a short apical process in contact with the ventricular lumen. Molecular fea-
tures of radial glial cells are typical of the astroglial lineage, with expression of brain 
lipid binding protein (BLBP), glutamate transporter GLAST and the adhesion molecule 
TN-C. In vivo lineage tracing and time lapse studies have shown that radial glia are the 
source of postmitotic neurons in the cerebral cortex (Malatesta et al., 2003) and possibly 
in the entire telencephalon (Anthony et al., 2004; Noctor et al., 2002). 
It is noteworthy that not all the neuroepithelial cells divide at the ventricular wall; 
around the time of radial glial appearance, some of these cells undergo mitosis at a dis-
tance from the apical surface, giving rise to basal progenitors, at a border between the 
VZ and the preplate known as the subventricular zone (SVZ). The SVZ is formed 
around E13.5 and expands during late corticogenesis, forming mainly upper-layer neu-
rons. In some regions of the CNS, for example in the ventral telencephalon, the basal 
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progenitor cells alongwith the radial glia, which are far less in number, are the main 
source of neurons. However, at late fetal and early postnatal ages these basal progeni-
tors become restricted to a glial lineage (Malatesta et al., 2008; Molyneaux et al., 2007). 
Figure 8. Progenitor cells in developmental neurogenesis. The neuroepithelial cells (white) give rise to 
the very first preplate neurons (green) and then progressively convert into basal progenitors (red) of the 
SVZ and radial glial cells (gray). Neurons are derived at early stages by basal progenitors and at later 
stages they are derived from both radial glia and basal progenitors (blue and green). CP, Cortical Plate; 
SVZ, Subventricular Zone; VZ, Ventricular Zone (adapted from Malatesta et al., 2008). 
1.3.2 Postnatal neurogenesis 
Adult neurogenesis is an intriguing feature and under unperturbed conditions occurs in 
two well-defined regions of the CNS: the SVZ of the lateral ventricles and the sub-
granular zone (SGZ) of the hippocampal dentate gyrus (Zhao et al., 2008). Neurons 
born in the adult SVZ migrate over a long distance through the rostral migratory stream 
(RMS) to become granule neurons and periglomerular neurons of the olfactory bulb. 
Neurons born in the adult SGZ migrate to the granule cell layer of the dentate gyrus to 
become dentate granule cells (Cameron and McKay, 2001). 
The neural progenitor cells of the developing brain persist in these distinct regions of 
the postnatal brain and continue to produce glial cells, as well as neurons. In the late 
embryonic and early postnatal ages, the radial glial cells which were the precursor cells 
for neuronal cell types during embryonic development, now give rise to a discrete stem 
cell niche for postnatal neurogenesis. The neural stem cells of the SVZ is a relatively 
quiescent cell population known as type B cells, which give rise to actively proliferating 
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type C cells that function as intermediate or basal progenitors or transit amplifying cells 
in the adult SVZ. The type C cells in turn generate immature neuroblasts known as type 
A cells, which are directed towards the olfactory bulb by ensheathing glial tubes giving 
rise to the RMS (Doetsch, 2003).  
While, neurogenesis occurs from specialised progenitor neural stem cells, several in 
vivo fate mapping studies in the recent past have also suggested that progenitor cells of 
the oligodendroglial lineage or OPCs possess a neuronogenic potential.  
1.4 Aim of the study 
Oligodendroglial precursor cells (OPCs) or NG2 cells are abundant in the developing 
and mature CNS. During development, it is accepted that these cell types serve as pro-
genitors to oligodendroglial cells. However, culture studies have shown that OPCs 
could return to a multipotent state, suggesting that oligodendroglial lineage-restricted 
precursors might have a latent stem cell potential. A multitude of in vivo OPC lineage 
studies have in the past revealed contradictory results vis-à-vis their astrogliogenic and 
neuronogenic potential in the normal and compromised brain. Therefore, the primary 
objective of this study is to elucidate OPC fate choice and resolve the ambiguity in the 
field of oligodendroglial lineage development. Importantly, I will focus on a later time-
point during the development of an individual OPC. In order to preferentially study 
these relatively differentiated or “late OPCs”, a Cnp-based experimental approach will 
be employed, as the Cnp gene product- CNPase is expressed only in mature oligoden-
droglial cells. The main advantage of using CNP, instead of other oligodendroglial line-
age-specific markers which are expressed starting from early OPC development is that 
only once an OPC has made the “decision” to differentiate, its pattern of gene expres-
sion undergoes change and it first starts to show Cnp promoter activity.  
To eliminate any cell type-specific bias due to choice of reporter mice, Cre-lox strategy 
with two different Cre reporter lines will be employed to compare OPC cell fates. 
In addition to their role as progenitor cells, OPCs also establish direct synaptic contact 
with neurons. It is speculated that glutamatergic synaptic input onto OPCs via AMPA 
receptors could influence their physiology by activating several Ca++ dependent signal-
ling cascades. In my second research goal, I will investigate the influence of the GluRB 
subunit of the AMPA receptor on OPC behaviour in vivo: on its proliferation and differ-
entiation. 
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2 Materials and Methods 
2.1 Animals 
Animal housing was performed according to the institutional guidelines at the animal 
facility of the University of Bonn. Animals were maintained with a continuous supply 
of food and clean drinking water. 
2.1.1 C57BL/6 mice 
“C57 black 6” or simply “black 6” is probably the most widely used of all inbred 
strains. It originated in the 1920’s; substrain 6 was separated prior to 1937 and has gone 
through over 150 generations of full sibling matings. It has good breeding capacity and 
has been used as a genetic background for a large number of congenic strains covering 
both polymorphic and mutant loci. Its genome carries elements of Mus musculus and 
Mus spretus. C57BL/6 mice have a dark brown, nearly black coat, are easily irritable 
and have a tendency to bite. Mice were obtained from Charles River. 
2.1.2 CD1 mice 
Crl:CD1 (ICR) mice or CD1 mice were originally derived from a strain of Swiss mice 
that served as progenitors. These albino mice are widely used due to characteristics like 
easy handling, rapid growth, docile behaviour and high reproduction rate. Mice were 
obtained from Charles River and then bred in house.  
2.1.3 CNP-Cre mice 
Mice expressing Cre recombinase under control of the Cnp1 regulatory sequence have 
been generated and characterised by Dr. KA Nave, MPI Göttingen (Lappe-Siefke et al., 
2003), using a combined knockout and knock-in strategy. Utilizing homologous recom-
bination, the coding region of Cnp1 gene, encompassing most of exons 1 to 3 was re-
placed with Cre recombinase gene. The targeted mutation was confirmed by showing 
complete loss of CNP enzymatic activity in homozygous mice and 50% reduction of 
enzymatic activity in heterozygous mutants; it was also shown that no other protein 
compensated for the enzymatic action of CNP. Onset of Cre expression begins in the 
spinal cord by embryonic day 13.5 (Genoud et al., 2002). CNP deficient mice show no 
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obvious abnormalities until 4 months of age, however after that mutant mice develop 
ataxia and hindlimb impairments. Homozygous CNP-Cre+/+ mice develop axonal pa-
thology at 3-4 months of age and have a reduced life span, with most animals dying 
between 7-11 months of age. Homozygous CNP-Cre+/+ mice were obtained from MPI 
Göttingen, bred in house and maintained on a C57 black background. CNP-Cre+/- mice 
were inter-bred with other CNP-Cre+/- mice and also with wild type C57BL/6 mice to 
get CNP-Cre+/+ and CNP-Cre+/- mice. 
2.1.4 Z/EG mice 
The lacZ/EGFP is a Cre double reporter line developed by Novak et al. (2000), and can 
be used to report Cre excision from embryonic to adult ages. The Z/EG transgene con-
sists of a strong pCAGGS promoter, directing expression of a loxP-flanked βgeo fusion 
gene and three polyA sequences. Following that there is the coding sequence of the en-
hanced green fluorescent protein (EGFP) and a polyA sequence. In this configuration 
βgeo is expressed before Cre mediated excision and the expression of EGFP occurs 
after Cre excision. EGFP expression is strong enough in these mice and can be moni-
tored in the live cells/slices. These mice were bred for three generations with CD1 mice 
by the donating investigator and for one generation with C57BL/6 mice. We obtained 
this strain from Jackson Laboratories as hemizygotes on a SV 129 background and then 
subsequently crossed them for atleast 4-6 generations with C57BL/6 mice. 
2.1.5 ROSA26/EYFP mice 
The ubiquitously expressed ROSA26 locus is subject to targeted insertion of the en-
hanced yellow fluorescent protein (EYFP) cDNA, preceded by a loxP-flanked stop se-
quence (Srinivas et al., 2001). The expression of EYFP ensues upon Cre-mediated exci-
sion of the stop sequence upon homologous recombination at the loxP sites which are 
oriented in the same direction. Mice were obtained from Dr. Martin Theis (IZN, Bonn) 
as heterozygotes, and maintained them against a C57 black background. 
2.1.6 NG2creERTMBAC transgenic mice 
BAC modification technique is used to generate mice that express Tamoxifen-inducible 
Cre (CreERTM) specifically in NG2-expressing cells. The nls-CreERTM cDNA that con-
tains the coding region of Cre with a nuclear localization signal was inserted in the first 
exon of the ng2 gene. Upon crossing with the ROSA26/EYFP Cre reporter, no back-
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ground reporter activity was observed in the absence of Tamoxifen (TMX). On the oth-
er hand, Cre induction resulted in reporter expression (see section 2.2.2). The 
NG2creERTMBAC mice were obtained from Dr. Nishiyama (Zhu et al., 2011) and main-
tained as homozygotes against a C57 black background. 
2.1.7 NG2DsRedBAC transgenic mice 
These mice were obtained from Dr. Akiko Nishiyama as homozygotes. Here, DsRedT.1 
(Bevis and Glick, 2002), which is a variant of the original red fluorescent protein 
DsRed1, was inserted into the first exon of the ng2 gene in the BAC clone. The result-
ing transgenic mice express DsRed protein specifically in NG2+ cells (Zhu et al., 
2008a). In our lab we maintained these mice on a C57 black background. The fraction 
of NG2 cells that were DsRed positive were examined in the adult NG2DsRedBAC 
line; in the Dorsal Cortex ~80% of all NG2 cells were DsRed+ and in the Corpus Callo-
sum ~90% of all NG2 cells exhibited DsRed fluorescence. 
2.1.8 PGK-Cre transgenic mice 
The PGK-Cre mice (Lallemand et al., 1998) were obtained from Dr. Martin Theis (IZN, 
Bonn) and maintained on a C57 black background. The transgenic mice carry Cre re-
combinase controlled by the ubiquitously expressed PGK-1 promoter. 
2.1.9 GluRB2lox transgenic mice 
Gene-targeted mice with loxP sites flanking the GluRB gene (Gria2) exon 11 
(Shimshek et al., 2006), were obtained from Dr. R. Sprengel (MPI, Heidelberg) as ho-
mozygotes and we maintained these mice on a C57 black background. For experiments 
to generate NG2 cell specific GluRB knockouts, mice heterozygous for the GluRB al-
lele (GluRB2lox/wt) were inter-bred, such that a GluRB knock out (GluRB2lox/2lox) and 
wild type mice (GluRBwt/wt) were obtained from the same litter. 
2.2 Cross-breeding of mouse lines 
2.2.1 Generation of CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP mice  
The CNP-Cre line (CNP-Cre+/+ and CNP-Cre+/-) was inter-bred with the Z/EG and RO-
SA26/EYFP reporter lines (both homozygous and/or heterozygous), generating CNP-
Cre:Z/EG and CNP-Cre:ROSA26/EYFP respectively.  
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For experiments in this study both double heterozygotes and double homozygotes were 
used at embryonic and postnatal ages as indicated, since no difference in reporter ex-
pression was observed between CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP mice 
with CNP-Cre+/+ or CNP-Cre+/- genotype. In cells that have undergone Cre-loxP medi-
ated recombination, permanent expression of enhanced green fluorescent protein 
(EGFP) and enhanced yellow fluorescent protein (EYFP) occurs in CNP-Cre expressing 
cells and their progeny.  
Figure 9. Specificity of CNP-Cre expression. A,B, Frontal sections through the Dorsal Cortex (A) and 
Corpus Callosum (B) of CNP-Cre-/-:ROSA26/EYFP mice at P10 immunolabelled for GFP. C,D, Frontal 
sections through the Dorsal Cortex (C) and Corpus Callosum (D) of CNP-Cre+/-:ROSA26/EYFP mice at 
P10 immunolabelled for GFP. E-G, Sections through the Heart (E), Liver (F) and Brain (G) of CNP-Cre+/-
:ROSA26/EYFP mice at P30, immunolabelled for GFP. GFP (green) is used to indicate EYFP fluores-
cence. Scale bars: 50 µm (applied to all).  
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2.2.1.1 Reporter expression is committed under the Cnp promoter  
In the CNP-Cre:ROSA26/EYFP transgenic mice where I observed EYFP expression by 
non-oligodendroglial lineage cells, the Cre dependence of reporter expression was veri-
fied. For this control experiment, CNP-Cre:ROSA26/EYFP mice with CNP-Cre null 
homozygosity i.e. CNP-Cre-/-:ROSA26/EYFP+/- were examined. With GFP immuno-
labellings at P10, no EYFP+ cells were seen throughout gray and white matter regions 
in 50 µm frontal sections of the forebrain (n=2 animals) (Figure 9A,B).  
In my next set of experiments to check if the knock-in of Cre was stringently under the 
Cnp promoter, I checked the non-neural tissues of heart and liver where Cnp promoter 
activity is absent, for reporter positivity. I failed to observe any EYFP+ cells in the heart 
and liver tissues of P30 CNP-Cre+/-:ROSA26/EYFP+/- animal upon GFP immunolablel-
ing (Figure 9E,F), while reporter positive cells were observed in the forebrain frontal 
sections of the same animal (Figure 9G). 
2.2.2 Generation of other transgenic lines  
NG2creERTMBAC:ROSA26/EYFP transgenic mice: Homozygous and/or heterozy-
gous NG2creERTMBAC mice were inter-bred with homozygous and/or heterozygous 
ROSA26/EYFP Cre reporter line. For experiments in this study both double heterozy-
gotes and double homozygotes were used at embryonic ages for Tamoxifen injection. 
Using this strategy, NG2-expressing cells and their descendants will express enhanced 
yellow fluorescent protein (EYFP) upon Cre mediated recombination, only upon Ta-
moxifen induction.  
To check for any “leaky Cre expression”, control experiments were performed in which 
~P9 NG2creERTMBAC:ROSA26/EYFP mice were administered only 50 µl corn oil or 
NaCl (2 i.p injections per day for 3 days) and subsequently analysed ~24 hrs. after the 
last injection with GFP immunohistochemistry to identify any GFP-labelled cells. I did 
not observe any GFP+ cells in these control animals. 
Upon embryonic (E16.5) and postnatal (P6) TMX administration at a dosage of 6 mg 
and 0.5 mg (explained in detail in section 2.6), a number of EYFP+ cells were observed 
in the adult gray (Dorsal cortex, Hippocampus and Ventral Cortex) and white matter 
regions (Corpus Callosum and Fimbrae). Reporter positive NG2+ cells were seen at 
E19.5 (TMX at E16.5) in the Dorsal Cortex and Ventricular Zone (see section 3.10). 
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NG2creERTMBAC:GluRB2lox:ROSA26/EYFP:NG2DsRed mice: To specifically 
knock out the GluRB subunit in OPCs an interbreeding strategy was employed, where 
mice heterozygous for the floxed GluRB allele (GluRB2lox/wt) were inter-bred with ho-
mozygous and/or heterozygous NG2creERTMBAC mice (described elsewhere in section 
2.1.6).  
Furthermore, the ROSA26/EYFP Cre reporter line is used to permanently label NG2 
cells and their progeny that as a result of Cre-mediated recombination have either lost 
the GluRB subunit, in case of the GluRB2lox/2lox genotype: the GluRB knockouts and in 
NG2 cells that still possess the GluRB subunit, in case of the GluRBwt/wt genotype. For 
this, mice heterozygous for GluRB i.e. GluRB2lox/wt were cross-bred to each other, to 
yield both GluRB2lox/2lox and GluRBwt/wt genotypes. 
These triple transgenic mice were additionally bred with the NG2DsRed line with an 
aim to easily identify all NG2 cells for future patch clamp experiments. 
2.3 Tissue processing 
Preparation of frontal brain sections of postnatal animals 
Mice were anaesthetised in a small bell jar with a few drops of Isofluran, following 
which they were sacrificed by decapitation. The head was taken on a flat surface and 
using fine scissors the scalp was slit open and loosened, then the skull, along with the 
dura was opened. The brain was “scooped out” using a fine curved spatula into a glass 
beaker containing ice cold solution of sucrose preparation solution of the following 
composition (in mM): 87 NaCl, 2.5 KCl, 1.25 NaH2PO4, 7 MgSO4, 0.5 CaCl2, 25 Na-
HCO3, 25 glucose, 75 sucrose, gassed with 95% O2 and 5% CO2 mixture.  
Next, the brain was placed onto a pre-cooled metal dissection plate with sucrose solu-
tion to cut off the cerebellum- following which the trimmed brain was glued frontally 
onto a specimen disc using super glue (UHU®). This disc was fitted in the buffer tray 
containing ice cold sucrose solution and this set up was placed in the cooling bath (filled 
with crushed ice) of the vibratome (Leica VT1000 S, Leica VT1200 S and Thermosci-
entific Microm HM650V). 400 µm frontal slices were cut starting at the level of the 
olfactory bulb, using the vibratome with an amplitude of 1 mm and a speed of 0.22 
mm/s.  
Subsequent to slicing the entire brain, all the 400 µm slices were transferred to a beaker 
of sucrose preparation solution at 35° C. After the slices were incubated in warm su-
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crose preparation solution for 25 minutes, they were allowed to cool in the same solu-
tion at room temperature after which the slices were fixed overnight in 8% paraformal-
dehyde (PFA) (in PBS; pH 7.44).   
Preparation of frontal brain sections of embryonic animals 
Embryos aged days 18, 16, 12.5, 10.5 and 8.5 were obtained by opening the abdominal 
cavity of the pregnant dam after decapitation. The embryos were separated from the 
placenta and the yolk sac was removed, after which the embryos were transferred to ice 
chilled pre-gassed sucrose preparation solution. The brains were carefully dissected out 
of the cranial cavity and embedded in 5% Agar to facilitate the slicing procedure. 400 
µm slices were cut and processed pre-fixation as explained above for postnatal animals. 
At E12.5 and E10.5, whole embryos were fixed in 8% PFA. 
After overnight fixation in 8% PFA, all tissue was re-sectioned to 50 µm, following 3 
times 10 minute washes in PBS on a Leica VT1000 S vibratome. All sections were pre-
embedded in agar to facilitate re-sectioning. 
Figure 10. Schematic illustration of frontal forebrain slices. Frontal plane and a section of postnatal 
day 6 mouse brain, adapted from Atlas of the Developing Mouse Brain by Paxinos et al. (2007). D.Ctx, 
Dorsal Cortex; CA1 field of the Hippocampus; CC, Corpus Callosum; Fim, Fimbrae; V.Ctx, Ventral 
Cortex; Piri.Ctx, Piriform Cortex. 
2.4 Immunohistochemistry 
50 µm free-floating sections were first incubated with primary antibody in TBS contain-
ing 0.2% Triton X-100 overnight at 4° C. After 3 times 10 minute washes in TBS, anti-
bodies and detection were each applied for 3 hrs. at 35° C with sections incubated in 
TBS containing 0.2% Triton X-100. Secondary detection was carried out by using bio-
tinylated secondary antibodies, followed by incubation with streptavidin-conjugates. 
Dye-conjugated secondary antibodies were frequently used (see Table 1).  
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For counterlabelling of nuclei, I used Neurotrace fluorescent Nissl stain in the Cy5 
emission range. 
Table 1. The source and dilution of all antibodies used in this study. 
Antibodies Source Dilution used
Primary
Rabbit anti-NG2 Chemicon 1:500
Rabbit anti-GFAP DakoCytomation 1:250 - 1:500
Mouse anti-NeuN Chemicon 1:250
Goat anti-GFP FITC Abcam 1:166.6
Chicken anti-GFP Invitrogen 1:200 - 1:400
Rabbit anti-GFP Invitrogen 1:200
Rat anti-BrdU AbD Serotec 1:71.4 - 1:166.6
Mouse anti-APC (CC1 clone) Chemicon 1:400
Rabbit anti-BLBP Abcam 1:250
mouse anti-CNPase Sigma Aldrich 1:100
Secondary
Donkey anti-chicken Biotin Jackson Immunoresearch 1:200
Goat anti-rabbit Biotin Vector 1:200
Biotin anti-rat Jackson Immunoresearch 1:100 - 1:500
Sheep anti-mouse Biotin Serotec 1:200 and 1:4000 
Goat anti-mouse Alexa 555 Invitrogen 1:200
Goat anti-rabbit Alexa 488 Invitrogen 1:200
Streptavidin DyLight 488 Jackson Immunoresearch 1:200
Goat anti-rabbit Rhodamine Red-X Jackson Immunoresearch 1:200
Streptavidin Cy2 Jackson Immunoresearch 1:200
Streptavidin Cy5 Jackson Immunoresearch 1:200
Streptavidin Alexa 555 Invitrogen 1:200
Streptavidin Rhodamine Red-X Jackson Immunoresearch 1:200
Streptavidin Cy3 Jackson Immunoresearch 1:200
Counterstain
Nissl deep red Invitrogen 1:100 - 1:200
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NG2-GFP double immunohistochemistry: The two primary antibodies, rabbit anti-
NG2 and chicken anti-GFP were applied simultaneously in TBS containing 0.2% Triton 
X-100 overnight at 4° C. Next, donkey anti-chicken biotin was applied for 3 hrs. at 35° 
C, following which in the last step, the sections were incubated with Streptavidin Dye-
light-488 and goat anti-rabbit RRX.  
GFAP-GFP double immunohistochemistry: The two primary antibodies, rabbit anti-
GFAP and chicken anti-GFP were applied simultaneously in TBS containing 0.2% Tri-
ton X-100 overnight at 4° C. Next, donkey anti-chicken biotin was applied for 3 hrs. at 
35° C, following which in the last step, the sections were incubated with Streptavidin 
Dyelight-488 and goat anti-rabbit RRX.  
NeuN-GFP double immunohistochemistry: The two primary antibodies, mouse anti-
NeuN and chicken anti-GFP were applied simultaneously in TBS containing 0.2% Tri-
ton X-100 overnight at 4° C. Next, donkey anti-chicken biotin was applied for 3 hrs. at 
35° C, following which in the last step, the sections were incubated with Streptavidin 
Dyelight-488 and goat anti-mouse Alexa 555.  
CC1-GFP double immunohistochemistry: Especially in this reaction, the CC1 and 
GFP labelling steps were carried out sequentially to avoid cross-reactivity (see below). 
Free floating 50 µm sections were incubated with the primary antibody, mouse anti-
APC in TBS containing 0.2% Triton X-100 and 2% normal horse serum overnight at 4° 
C. Since primary antibody is raised in mouse and applied on mouse forebrain sections, 
this could result in highly unspecific labelling as the anti-mouse secondary antibody 
would recognise all endogenous epitopes in the mouse tissue. To reduce this unspecific 
epitope-antibody interaction (blood vessels, background etc.), the mouse primary Ab is 
applied alongwith horse serum. Horse serum would ensure that all unspecific binding 
sites have horse antibodies stuck to them and these unspecific epitopes will not be rec-
ognized by the anti-mouse secondary antibody. Next, sheep anti-mouse biotin was ap-
plied for 3 hrs. at 35° C, following which the slices were incubated with Streptavidin 
RRX for 3 hrs. at 35° C. Subsequent to CC1 labelling, the GFP labelling was per-
formed. Rabbit anti-GFP was applied to the sections overnight at 4° C and then the slic-
es were incubated with goat anti-rabbit Alexa 488 for 3 hrs. at 35° C. 
CNP-NG2-GFP double immunohistochemistry: In this reaction, the CNP, GFP and 
NG2 labelling steps were carried out sequentially. First, free floating 50 µm sections 
were incubated with the primary antibody, mouse anti-CNPase in TBS containing 0.2% 
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Triton X-100 and 2% normal horse serum overnight at 4° C. As explained, horse serum 
was used to reduce unspecific epitope-antibody interaction, since the host species of the 
primary antibody for CNPase was mouse. This was developed with an Alexa conjugated 
secondary antibody-goat anti-mouse Alexa 555 for 3 hrs. at 35° C. Next, the GFP label-
ling was performed. Chicken anti-GFP was applied to the sections overnight at 4° C and 
then the slices were incubated with goat anti-chicken Alexa 488 for 3 hrs. at 35° C. 
Lastly, NG2 labelling was performed. Rabbit anti-NG2 was applied to sections over-
night at 4° C, after which slices were incubated with goat anti-rabbit biotin for 3 hrs. at 
35° C and then developed with Streptavidin Cy5 which was applied for 3 hrs. at 35° C. 
BrdU-GFP double immunohistochemistry: Here, the GFP and BrdU labelling steps 
were performed sequentially since HCl pre-treatment for BrdU labelling leads to ex-
treme denaturing of the tissue and loss of the other antigen- in this case GFP. Therefore, 
first the GFP immunoreaction was carried out. Slices were incubated with rabbit anti-
GFP overnight at 4° C and then goat anti-rabbit Alexa 488 was applied for 3 hrs. at 35° 
C. After this slices were incubated in 2N HCl for 30 min. Following a more intensive 
washing out step i.e. 4 times 10 min with TBS, the primary antibody, rat anti-BrdU was 
applied overnight at 4° C. Next, slices were incubated with highly cross adsorbed biotin 
anti-rat for 3 hrs. at 35° C and then Streptavidin Cy5 was applied, again for 3 hrs. at 35° 
C. It is important to note that in this double labelling protocol only 0.06% Triton X-100 
was used at each step, to preserve the antigens in the section since HCl pre-treatment for 
BrdU labelling strongly denatures the slice. 
NG2-GFP-BrdU double immunohistochemistry: As explained above, to prevent the 
denaturing of the NG2 and GFP antigens by the strong HCl denaturing pre-treatment 
used for BrdU labelling, the NG2 and GFP labelling steps were performed before the 
BrdU labelling step. The two primary antibodies, rabbit anti-NG2 and chicken anti-GFP 
were applied simultaneously overnight at 4° C. For secondary detection, goat anti-rabbit 
RRX and goat anti-chicken Alexa 488 were applied for 3 hrs. at 35° C. After this slices 
were incubated in 2N HCl for 30 min. Following a more intensive washing out step i.e. 
4 times 10 min with TBS, the primary antibody, rat anti-BrdU was applied overnight at 
4° C. Next, slices were incubated with highly cross adsorbed biotin anti-rat cross SP for 
3 hrs. at 35° C and then Streptavidin Cy5 was applied, again for 3 hrs. at 35° C. It is 
important to note that in this double labelling protocol only 0.06% Triton X-100 was 
used at each step, to preserve tissue condition. 
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BLBP-GFP double immunohistochemistry: The two primary antibodies, rabbit anti-
BLBP and chicken anti-GFP were applied simultaneously in TBS containing 0.2% Tri-
ton X-100 overnight at 4° C. Next, donkey anti-chicken biotin was applied for 3 hrs. at 
35° C, following which in the last step, the sections were incubated with Streptavidin 
Dyelight-488 and goat anti-rabbit RRX.  
All immunolabelled sections were mounted in Vectashield (Vector Laboratories). 
2.5 BrdU labelling 
In order to perform proliferation assays in the three transgenic mouse lines, BrdU was 
administered to both embryonic and adult animals via different routes of delivery. 
BrdU administration to CNP-Cre:ROSA26/EYFP mice 
Intraperitoneal injections 
P10 mice were administered 2 i.p injections of 100 mg/kg BrdU over a 12 hr. period for 
4 days until P13 (Figure 11). 
Figure 11. Postnatal BrdU administration protocol. BrdU was administered from P10 to P30 and ani-
mals were analysed at P30. 
Wildtype mice were administered 100 mg/kg BrdU dissolved at 16.2 mg/ml in 0.9% 
NaCl, with 4 i.p injections per day for 4 days. 
Oral gavage  
BrdU was administered to timed pregnant dams at E12.5 orally at a dosage of 50 mg/kg 
of BrdU dissolved at 16.2 mg/ml in 0.9% NaCl, twice a day (4 hours apart) for one day 
only (Figure 12). This technique was established with the help of Gabriela Bodea (Insti-
tute of Reconstructive Neurobiology, UKB). The pregnant animal was held horizontally 
and the rounded rubber tipped animal feeding needle (Fine Science Tools; cat No. 9921, 
size: 20G x 1-1/2´´) was inserted in to its oral cavity, allowed to pass freely through the 
oesophagus up until the last rib cage. Great care was taken not to damage the trachea 
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and in case even minimum resistance was experienced, the needle was withdrawn and 
the procedure tried again. Subsequent to de-scruffing the animal, it was allowed to rest 
in a separate holding cage where it was monitored for 30 min for any changes in vital 
signs. The female was allowed to deliver normally and litters were prepared at P30 and 
subject to required immunolabellings. Pregnant wildtype mice were i.p injected at E16 
with 50 mg/kg BrdU dissolved at 16.2 mg/ml in 0.9% NaCl, four times a day (over 12 
hours) for one day only. 
Figure 12. Embryonic BrdU administration protocol. BrdU was administered at E12.5 and 
animals were analysed at P30. 
BrdU administration to NG2creERTMBAC:GluRB2lox:ROSA26/EYFP:NG2DsRed 
mice 
Adult mice (P10-P32) which had already been injected with Tamoxifen to induce Cre 
recombination (read below) , were administered 1 i.p injection of BrdU 2-3 hours prior 
to sacrifice at a dosage of 300 mg/kg dissolved at 16.2 mg/ml in 0.9% NaCl). All mice 
were administered BrdU upon actual weighing to calculate the exact BrdU dosage.  
2.5.1 Identification of EYFP+ cells as neurons based on morphological 
criteria 
In the BrdU labelling experiments, reporter positive neurons were identified on basis of 
morphology, as having a large round to oval cell body, with a long axonic process and 
invariably a few dendrites. NeuN immunolabellings could not be used to ascertain the 
neuronal phenotype, since NeuN immunohistochemistry did not work well with HCl 
pre-treatment used for BrdU labelling. In order to substantiate that neurons were identi-
fied correctly based on their morphology, analogous scans were performed on NeuN-
GFP labelled sections. I was blind to the channel used to scan the NeuN+ cells during 
the analysis procedure, so first I marked all EYFP+ cells that as per the criteria de-
scribed above looked like neurons. Next, I saw using the NeuN channel if my identifica-
tion of neurons based on morphology was correct and these cells indeed co-labelled 
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with NeuN. The fraction of NeuN+ neurons amongst those identified purely by mor-
phology was 0.99 ± 0.004 (total of 208 EYFP+ neurons, n=3 animals), 0.97 ± 0.004 
(total of 112 EYFP+ neurons, n=3 animals) and 0.98 ± 0.01 (total of 77 EYFP+ neu-
rons, n=3 animals), in the dorsal, piriform and ventral cortices. This establishes that the 
stringent morphological characteristics criteria used to ascertain neuronal cells were 
indeed appropriate. 
2.6 Induction of Cre-mediated recombination with Tamoxifen 
Cre activity was induced in embryonic NG2creERTMBAC:ROSA26/EYFP double 
transgenic mice by administering 6 mg of Tamoxifen to pregnant at E16.5 via gastric 
gavage using 20-gauge curved stainless steel feeding needles with round tips (Figure 
13). Tamoxifen (TMX) (Sigma) was dissolved in corn oil preheated to 35° C, at a con-
centration of 20 mg/ml, mixed with 5mg/ml Progesterone, in a lengthy process of re-
petitive sonications at the same temperature. It is essential to note that no ethanol was 
used for dissolution. In postnatal NG2creERTMBAC:ROSA26/EYFP mice, 0.5 mg 
TMX was administered at P6 at a concentration of 10 mg/ml (single i.p injection). 
Figure 13. Embryonic Tamoxifen induction protocol. Tamoxifen was administered at E16.5 and the 
three time points of analysis were at E19, P14 and P30. 
In NG2creERTM:GluRB2lox:ROSA26/EYFP:NG2DsRed transgenic mice, Cre activity 
was induced by administering 0.5 mg of TMX to postnatal mice at ages ranging from 
P5 to P20 via intraperitoneal injections using a disposable insulin syringe with a needle 
specification of 30G x ½´´ (0.3 mm x 12 mm) (single i.p injections for 1 or 6 days, see 
sections 3.11 and 3.12). A stock solution of 10 mg/ml was prepared by dissolving and 
sonicating Tamoxifen in 19.9:0.1 corn oil:ethanol. 
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2.7 Virus transfections 
Viral vector production 
Recombinant AAV1/2 and AAV8 genomes were generated by the working group of Dr. 
Susanne Schoch McGovern, with large scale triple transfection of HEK293 cells. The 
rAAV plasmids: CMV Venus, Efa-doublefloxed reverse-hChR2-EYFP and Ef1a-
DIO-EYFP-WPRE-pA, helper plasmids encoding genes for serotype ½ and 8 specifi-
cations, and adenoviral helper pFΔ6 (Stratagene) were transfected using standard CaPO4 
transfection. Cells were harvested ~60 hrs. following transfection. Cell pellets were 
lysed in the presence of 0.5% sodium deoxycholate (Sigma) and 50U/ml Benzonase 
endonuclease (Sigma). rAAV viral particles were purified from the cell lysate by Hi-
TrapTM heparin column purification (GE Healthcare) for Serotype1/2 and by a centrifu-
gation gradient for Serotype 8. Purity of the viruses was validated by coomasie blue 
labelling of SDS-polyacrylamide gels loaded with 7-15 µl of virus stock.  
 Virus injections 
As in the CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP lines, Cre-mediated reporter 
expression is constitutive, therefore a Cre reporter virus-based experimental strategy 
was employed. The rationale here was to transfect mice expressing Cre recombinase 
under the Cnp1 promoter while lacking any reporter genes i.e. a CNP-Cre +/-
:ROSA26/EYFP-/- and CNP-Cre +/-:Z/EG-/- genotype with Cre-dependent EYFP virus. 
Upon successful transfection of the virus, only transfected cells will be reporter positive 
under endogenous Cre expression, thus enabling one to follow fates of CNP-Cre ex-
pressing EYFP+ cells. To standardize the virus injection protocol, trials with varying 
volumes and frequency of injections were performed in neonatal mice.  
Neonatal injections: P1 PGK-Cre mice expressing Cre recombinase in all cells under 
the PGK promoter were cryoanesthetized for 2-4 minutes. After which they were placed 
on a flat cool surface and one intraventricular injection of the Efa-doublefloxed reverse-
hChR2-EYFP virus construct (Serotype 1/2) was made with a volume of 1 µl per ven-
tricle in both hemispheres using a 5 µl (33 gauge) Hamilton syringe.  
Next, the CMV-Venus virus construct (Serotype 8) was intraventricularly injected once 
a day with a volume of 1 µl in only one ventricle in P1 mice. I also injected 3 µl of the 
same CMV-Venus construct in the cerebral ventricle of P2 mice, twice a day for two 
days and then twice a day for one day. Postnatal day 3 CNP-Cre:Z/EG mice were intra-
ventricularly injected with 1 µl (in only one ventricle) of the Ef1a-DIO-EYFP-WPRE-
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pA virus construct. Additional to check the Cre dependent EYFP expression pattern of 
the above construct, 1 µl intraventricular injection in P2 wild type mice was performed.  
2.8 Solutions 
Sucrose preparation solution 
87 mM  NaCl 
2.5 mM KCl 
1.25 mM Na2HPO4 
7 mM MgCl2 
0.5 mM CaCl2 
25 mM NaHCO3 
25 mM Glucose 
75mM Sucrose 
pH 7.0 at 5° C and 7.6 at 35° C with carbogen 
Artificial cerebrospinal fluid (ACSF) for room temperature (RT) 
124 mM  NaCl 
3 mM KCl 
1.25 mM Na2HPO4 
2 mM MgCl2 
2 mM CaCl2 
26 mM NaHCO3 
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10 mM  Glucose 
   
   
pH 7.4 with carbogen 
 
Tris-buffered saline 0.1 mM 
100 mM  TRIS 
   
154 mM  NaCl 
   
pH 7.6 with 1 M HCl and 1M NaOH 
 
Phosphate-buffered saline 10 mM (1x) 
6.5 mM  Na2HPO4 
   
1.9 mM  NaH2PO4 
   
150 mM  NaCl 
 
pH 7.4 with 1M HCl and 1M NaOH 
 
Fixation medium 8% Paraformaldehyde (PFA) 
8 g  PFA 
   
100 ml  1 mM PBS 
   
12 drops  1 M NaoH 
   
6 drops  1 M HCl 
 
pH 7.4 with 1 M HCl and 1 M NaOH 
 
Cryostorage Glycol Solution 
1% (w/v)  PVP-40 Polyvinylpyrolidone 
   
30% (w/v) Sucrose 
2 Materials and Methods 46 
   
30% (w/v) Ethylene Glycol 
   
0.2 M  PB 
 
Phosphate Buffer 0.2 M 
0.2 mM  Na2HPO4 
   
0.04 mM NaH2PO4 
 
pH 7.4 with 1 M HCl and 1M NaOH 
2.9 Image acquisition 
Sections were scanned with a confocal laser scanning microscope (Leica TCS NT, 
equipped with an Argon-Krypton laser) and images with different dyes (eg. Dyl 488, 
RRX and fluorescent Nissl Cy5) were acquired sequentially. For Dyl 488 or Cy2, the 
following laser lines and filters were used: excitation 488 nm, triple dichroic (TD- 
488/568/633), pass through reflection short pass 580 nm, emission band pass 530/30 
nm. For RRX or Cy3 we used: excitation 568 nm, triple dichroic (TD- 488/568/633), 
pass through reflection short pass 660 nm, emission band pass 600/30 nm. For Cy5 we 
used: excitation 647 nm, triple dichroic (TD- 488/568/633), emission long pass 665 nm. 
The majority of scans were acquired with a 63x objective (water; NA 1.2, correction 
ring, Leica) and the pinhole was set to 1 Airy unit. Laser power, detector gain and offset 
were adjusted such that in the final scan (4-10 averages) only a few pixels had zero or 
maximal (225) digital units. This means that few bright pixels in my sample signal were 
brought close to saturation (but not crossing it) i.e. close to white on a gray scale (blue 
pixels on pseudo glow over-under colour) and the darkest features were set to black 
(green pixels on pseudo glow over-under colour). Thus, the maximal and minimal de-
tection was set such that section was not scanned with over-saturation or under-scanned, 
and all biological features remained unchanged. Typically detector gain and offset were 
set to ~60-70% and ~6 digital units, respectively. The beginning and end of the confocal 
stack to be scanned was set to z positions in the entire slice thickness where no EGFP+ 
or EYFP+ cells were seen. And the numbers of sections in each stack were decided so 
as to get a voxel depth of 1.5 µm between two adjacent sections. Detector gain and off-
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set were set using the “Glow over- under” pseudo colour to ~70% and ~5-6 digital 
units, respectively. Photoshop was used to modify certain images: maximum brightness 
was rescaled to ~80% and a gamma correction factor of ~1-1.2 was introduced. 
2.10 Cell count and quantification 
To determine the postnatal phenotype EGFP+ or EYFP+ cells in the CNP-Cre:Z/EG 
mice and CNP-Cre:ROSA26/EYFP mice, frontal brain sections were investigated, 
around approximately -1.64 mm from Bregma at early postnatal, P6, P10 and late post-
natal, P30 ages. For cell count analysis, areas were chosen randomly within the indi-
cated brain regions (see Figure 10), all analysis were performed on 3-4 animals at each 
time point and 2-3 brain slices were used for each animal.  
Brain regions under analysis 
The regions of interest have been depicted in Figure 10. The dorsal cortex area under 
observation refers to the cerebral cortex above the corpus callosum that includes the 
primary and secondary motor cortex, primary somatosensory cortex and part of the ret-
rosplenial granular cortex. The selective region of the corpus callosum under observa-
tion is directly under the Indusium griseum and the entire fimbrae was scanned. In the 
hippocampus, the stratum radiatum region of the CA1 was under observation and the 
ventral cortex region refers to the cerebral cortex located ventrally down across from the 
rhinal fissure, including the amygdala. The piriform cortex is the cerebral cortex extend-
ing from the rhinal fissure up until the cortex-amygdala transition zone.  
Cell Counts  
During scanning, volume under analysis was approximately 9.763 x 105 µm3 (158.73 
µm x 158.73 µm x 1.55 µm x 25 sections) and great emphasis was placed on the fact 
that the total number of confocal stacks made per region per animals should in total in-
clude atleast 20-30 EGFP+ or EYFP+ cells. It is important to note here that I considered 
two antigens as co-localized only if the co-localization pattern extended from top to 
bottom of the z-plane extent of the cell concerned. The image analysis processing soft-
ware LSM 5 Image browser (Carl Zeiss) was used for cell identification and counts. The 
fractions presented in the results section as “fraction of EGFP or EYFP cells that were 
positive for a cell specific antigen” were calculated as follows: for each region, this 
fraction was calculated separately for each confocal stack, these fractions from different 
stacks were then averaged to obtain a value which represents the mean fraction for that 
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region for each animal. Final fractions for each region were calculated by averaging 
values across the number of animals. Standard error of mean (SEM) for each region has 
been calculated for fractions obtained from each animal. Fractions for each region are 
also mentioned alongwith total cell number which has been calculated for each region 
across all stacks and all animals. Absolute numbers of cells were all normalized to the 
“z-extent”, which was calculated by multiplying the voxel size by the number of frames 
containing cells in each stack. The value for the number of frames containing cells in 
each stack was calculated by examining all frames of a stack and removing “empty or 
black” frames on the bottom and end of the stack. It is also important to note that abso-
lute cell numbers were subject to correction for brain size, as the developing postnatal 
brain increases in volume from postnatal day 6 to postnatal day 30. Therefore, absolute 
cell numbers at P10 were all multiplied by a factor of 1.2 (volume of brain at 
P10/volume of brain at P6; i.e. 480 mm3/400 mm3) and absolute cell numbers at P30 
were multiplied by a factor of 1.63 (volume of brain at P30/volume of brain at P6; i.e. 
650 mm3/400 mm3). It is important to note that absolute cell numbers counted, include 
cells lying at the three defined borders of the slice (x,y,z), this may lead to an over esti-
mation of cell numbers, but in my experiments this degree of over-sampling would be 
present across all groups being compared; thereby cancelling out this error in cell num-
ber estimation. Moreover, the difference between absolute cell numbers between re-
gions, groups and ages was always more than 10% in my experiments which maybe 
another reason to disregard the sampling error. 
To determine Cre reporter expression, by the presence of EGFP+ or EYFP+ cells in the 
CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP mice at both postnatal and embryonic 
ages, 400 µm live slices were first viewed before PFA fixation under the Nikon Eclipse 
TS-100 fluorescence microscope equipped with a DS Camera control unit DS-L2. It 
was imperative to view live slice first to ascertain the frontal plane where the maximum 
number of reporter positive cells were found and to first process these slices for 50 µm 
re-sectioning. Examination of live slices also ensured determination of reporter positiv-
ity at the first instance, therefore saving time in the subsequent steps if no reporter posi-
tive cells were found. Subsequent to this step, immunolabellings and confocal scans 
were taken on the Leica confocal scanning microscope.  
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3 Results 
3.1 CNP-Cre mediated reporter expression in a subpopulation 
of NG2 cells  
The CNP-Cre knock-in approach was used to label oligodendroglial lineage and explore 
their fates. Therefore, in order to ascertain the cell population labelled by CNP-Cre me-
diated recombination, the fraction of NG2 positive oligodendroglial precursor cells 
(OPCs) that were EGFP or EYFP positive was determined. I chose an early postnatal 
day 6 (P6) time point for this experiment as it is a developmental period before the on-
set of myelination in gray matter. Gray and white matter regions (Figure 14A) of the 
CNP-Cre:Z/EG and the CNP-Cre:ROSA26/EYFP mouse lines were examined with 
double immunolabelling with antibodies against GFP and NG2. It should be noted that 
the GFP antibody would also recognise the EYFP antigen owing to cross-reaction. 
3.1.1 EGFP expression in a subset of NG2 cells in the CNP-Cre:Z/EG line 
In P6 CNP-Cre:Z/EG mice, the proportion of NG2 cells that were EGFP+ in the gray 
matter regions of the dorsal cortex (Figure 14C, arrowhead), CA1 and ventral cortex 
was 0.22 ± 0.02 (total of 255 NG2+ cells, n=4 animals), 0.2 ± 0.03 (total of 234 NG2+ 
cells, n=4 animals) and 0.35 ± 0.03 (total of 159 NG2+ cells, n=3 animals) respectively 
(Figure 14B). In the white matter regions of corpus callosum (Figure 14E, arrowheads) 
and fimbrae, this fraction was 0.15 ± 0.06 (total of 344 NG2+ cells, n=4 animals) and 
0.11 ± 0.06 (total of 505 NG2+ cells, n=4 animals) (Figure 14B) respectively. In both 
gray and white matter regions a number of NG2 cells did not display reporter positivity 
(Figure 14C,E, arrows; B). 
3.1.2 EYFP expression in a subset of NG2 cells in the CNP-
Cre:ROSA26/EYFP line 
In CNP-Cre:ROSA26/EYFP mice at the same age (P6), a significantly higher fraction 
of recombined NG2 cells i.e. NG2 cells that were reporter positive, was observed. For 
instance, in the dorsal cortex, the proportion of NG2 cells that were EYFP+ cells was 
0.64 ± 0.1 (total of 173 NG2+ cells, n=4 animals) (Figure 14D, arrowheads; B), and in  
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Figure 14. Reporter expression in NG2 cells in the CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP 
lines. A, Illustration of postnatal day 6 murine brain partial frontal section with anatomical structures of 
interest in this study. Highlighted areas denote regions where analysis was performed. Gray matter: Dor-
sal Cortex, Hippocampal CA1, Ventral Cortex and Piriform Cortex. White matter: Corpus Callosum and 
Fimbrae. B, Fraction of NG2 cells that were EGFP+ or EYFP+. Error bars indicate SEM (±). Two-way 
Anova with Bonferroni post-hoc test used to indicate significant difference. For CA1, * indicates p < 
0.01; for D.Ctx, V.Ctx, CC and Fim, * indicates p < 0.0001. C,D, Frontal sections through the Dorsal 
Cortex of CNP-Cre:Z/EG (C) and CNP-Cre:ROSA26/EYFP (D) mice at P6 immunolabelled for GFP 
(green), NG2 (red) and Nissl deep red (blue). C1-C2, D1-D2, represent maximum projections of the 
boxed areas in C,D at higher magnification. E,F, Frontal sections through the Corpus Callosum of CNP-
Cre:Z/EG (E) and CNP-Cre:ROSA26/EYFP (F) mice at P6 immunolabelled for GFP (green), NG2 (red) 
and Nissl deep red (blue). E1-E2, F1-F2, represent maximum projections of the boxed areas in E,F at 
higher magnification. All arrowheads point to GFP+/NG2+ cells. All arrows point to GFP-/NG2+ cells. 
GFP (green) is used to indicate EGFP and EYFP fluorescence. Scale bars: 10 µm (applied to all). D.Ctx, 
Dorsal Cortex; V.Ctx, Ventral Cortex; CC, Corpus Callosum; Fim, Fimbrae. 
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the corpus callosum this fraction was 0.72 ± 0.07 (total of 286 NG2+ cells, n=4 ani-
mals) (Figure 14F, arrowheads; B). 
It is noteworthy that at P6, in both experimental mouse lines a considerable population 
of NG2 cells that did not display any reporter positivity was observed (Figure 14C,E,F, 
arrows; B); and these NG2 cells represented a subset that was not labelled by CNP-Cre 
mediated recombination. 
Taken together these findings suggest that with the CNP-Cre knock-in based experi-
mental approach, a subpopulation of presumably relatively differentiated NG2 cells out 
of the entire OPC population, was selectively labelled. The next set of experiments were 
designed to elucidate the fate choice of precursor cells labelled by CNP-Cre mediated 
recombination, separately in the CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP lines. 
3.2 Analysis of reporter positive cells in the CNP-Cre:Z/EG 
line 
3.2.1 EGFP expression in mature oligodendrocytes in gray and white 
matter forebrain 
To ascertain whether CNP-Cre mediated EGFP expression was observed in mature oli-
godendrocytes, CNP-Cre:Z/EG animals were examined with double-labellings for GFP 
and oligodendrocyte stage specific markers: NG2 for labelling OPCs and mature oli-
godendrocyte specific adenomatosis polyposis coli (APC) clone CC1 (Bhat et al., 
1996). In order to encompass the predominant developmental period, P10- a time point 
immediately prior to the onset of myelinogenesis in the gray matter and an adult P30 
time point were chosen to examine the identity of reporter positive cells in the dorsal 
cortex and corpus callosum.  
The absolute number of EGFP+ cells (per 1x10-3 mm3) increased significantly from P10 
to P30, both in the dorsal cortex (P10, 3.9 ± 0.3 per 1x10-3 mm3; P30, 14.7 ± 2; p < 
0.05) and corpus callosum (P10, 24 ± 2.5 per 1x10-3 mm3; P30, 79 ± 10 per 1x10-3 mm3; 
p < 0.05) (Figure 15E).  
NG2-GFP co-labelling 
In the dorsal cortex, concomitant with this increase in the number of reporter positive 
cells with age, there was a reduction in the fraction of EGFP+ cells that were NG2+. 
The fraction of EGFP+ cells that were NG2+ OPCs decreased significantly from 0.74 ±  
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Figure 15. EGFP expression in mature oligodendrocytes in the CNP-Cre:Z/EG line. A-D, Frontal 
sections through the Dorsal Cortex (A,B) and Corpus Callosum (C,D) of P10 and P30 CNP-Cre:Z/EG  
mice, immunolabelled for GFP (green), NG2 (red) (A,C) and GFP (green), CC1 (red) (B,D). All white 
arrowheads point to GFP+/NG2+ cells. All white arrows point to GFP+/NG2- cells. All yellow arrow-
heads point to GFP+/CC1+ cells. All yellow arrows point to GFP+/CC1- cells. GFP (green) is used to 
indicate EGFP and EYFP fluorescence. Scale bars: 10 µm (applied to all). E, Histograms showing abso-
lute numbers of EGFP+ cells in the Dorsal Cortex and Corpus Callosum at postnatal days 10 and 30 in 
the CNP-Cre:Z/EG line. F-G, Histograms showing fractions (F) and absolute numbers (G) of reporter 
positive cells that were NG2+ OPCs and CC1+ mature oligodendrocytes in the Dorsal Cortex and Corpus 
Callosum at postnatal days 10 and 30 in the CNP-Cre:Z/EG line. Error bars indicate SEM (±). Student’s 
unpaired t-test used to indicate significant difference, * indicates p < 0.05. n.s, non-significant. D.Ctx, 
Dorsal Cortex; CC, Corpus Callosum. 
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0.09 (total of 76 EGFP+ cells, n=4 animals) at P10 to 0.3 ± 0.1 (total of 187 EGFP+ 
cells, n=4 animals) at P30 (Figure 15A, white arrowhead; F).  
In the corpus callosum at P10 only a small fraction of EGFP+ cells that were NG2 cells 
existed, 0.08 ± 0.03 (total of 232 EGFP+ cells, n=4 animals), and this further reduced to 
0.01 ± 0.01 (total of 1212 EGFP+ cells, n=4 animals) at P30 (Figure 15C,F). This is 
suggestive of differentiation.  
Also, the absolute number of EGFP+NG2+ cells per 1x10-3 mm3 decreased from P10 to 
P30. For instance, in the corpus callosum the number of EGFP+NG2+ cells decreased 
from ~2.2 ± 1 per 1x10-3 mm3 at P10 (n=4 animals) to 1.1 ± 0.7 per 1x10-3 mm3 at P30 
(n=4 animals) (Figure 15G). 
CC1-GFP co-labellings 
In the dorsal cortex, CC1-GFP co-labellings revealed that the fraction of EGFP+ cells 
that were CC1+ mature oligodendrocytes increased from 0.19 ± 0.09 (total of 39 
EGFP+ cells, n=2 animals) at P10 to 0.73 ± 0.01 (total of 127 EGFP+ cells, n=4 ani-
mals) at P30 (Figure 15B, yellow arrowhead; F).  
In the P10 corpus callosum, a large fraction of EGFP+ cells that were CC1+ oligoden-
drocytes already existed: 0.95 ± 0.01 (total of 109 EGFP+ cells, n=2 animals), and this 
increased to 0.96 ± 0.01 at P30 (total of 609 EGFP+ cells, n=4 animals) (Figure 15D, 
yellow arrowheads; F). The absolute numbers of reporter positive cells that were CC1+ 
mature oligodendrocytes was also calculated. The EGFP+CC1+ cell population in-
creased from 27 ± 5 per 1x10-3 mm3 (n=2 animals) at P10 to 73 ± 20 per 1x10-3 mm3 at 
P30 (n=4 animals) (Figure 15G). 
3.2.2 Lack of EGFP expression in astrocytes in the ventral cortex 
Next, I investigated whether CNP-Cre mediated EGFP expression was observed in as-
trocytes with double-immunolabellings for GFP to detect reporter positivity and for the 
astrocytic marker Glial fibrillary acidic protein (GFAP) (Bignami et al., 1972).  
Early postnatal day 6 and 10, as well as adult P30 CNP-Cre:Z/EG animals were exam-
ined for the presence of reporter positivity in GFAP+ astrocytes. Both at P6 and P10, no 
EGFP+ cells that co-labelled GFAP were observed amongst 831 reporter positive cells 
examined in gray and white matter regions (total of 831 EGFP+ cells; n=8 animals).  
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In the adult P30 brain too, almost no reporter positive cells co-expressing GFAP were 
observed. For example in the ventral cortex, the majority population of EGFP+ cells did 
not demonstrate any GFAP immunoreactivity (~98%) (Figure 16A, arrows). Out of the 
124 reporter positive cells examined in the ventral cortex of P30 CNP-Cre:Z/EG mice, 
only 2 EGFP+ cells (total of 124 EGFP+ cells; n=4 animals) were seen with a dense 
round cell body and a highly ramified bushy arbor of processes characteristic of proto-
plasmic astrocytes (Bushong et al., 2004), alongwith antigenicity for GFAP (Figure 
16B,B´; arrowheads). 
 
 
Figure 16. Absence of EGFP expression in ventral forebrain astrocytes in adult CNP-Cre:Z/EG 
animals. A,B, Frontal sections through the Ventral Cortex of P30 CNP-Cre:Z/EG mice double-
immunolabelled for GFP (green) and GFAP (red). B´ depicts the cell shown in the white boxed area in B 
at higher magnification. All arrowheads point to GFP+/GFAP+ cells. All arrows point to GFP+/GFAP- 
cells. GFP (green) is used to indicate EGFP and EYFP fluorescence. Scale bars: 20 µm (applied to all). 
Therefore, I did not find evidence of widespread astrocytic generation from CNP-
expressing precursor cells labelled in the CNP-Cre:Z/EG line. 
3.2.3 Absence of EGFP expression in neurons in the dorsal, ventral and 
piriform cortex 
To determine if CNP-Cre mediated EGFP expression was observed in neurons, I per-
formed GFP and the mature neuronal marker- NeuN (Mullen et al., 1992) at P30 in 
CNP-Cre:Z/EG mice.  
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In the P30 CNP-Cre:Z/EG mice, out of close to ~400 EGFP+ cells examined in four 
animals, only one or two EGFP+ cells with large cell bodies reminiscent of projection 
neurons and displaying NeuN immunoreactivity were seen. These negligible numbers of 
reporter positive neurons were observed only in the dorsal and piriform cortices.  
Predominantly however, the dorsal (total of 173 EGFP+ cells, n=4 animals) (Figure 
17A, arrows), ventral (total of 107 EYFP+ cells, n=4 animals) (Figure 17B, arrows) and 
piriform (total of 92 EYFP+ cells, n=4 animals) (Figure 17C, arrows) cortices were 
largely devoid of reporter positive cells displaying NeuN immunoreactivity.  
Thus in the adult CNP-Cre:Z/EG line, I did not observe any CNP-Cre mediated EGFP 
reporter expression in NeuN+ neurons. 
 
 
Figure 17. Absence of EGFP expression in neurons of the dorsal, ventral and piriform cortices in 
the adult CNP-Cre:Z/EG line. A-C, Frontal sections through the Dorsal Cortex (A) Ventral Cortex (B) 
and Piriform Cortex (C) of P30 CNP-Cre:Z/EG mice double-immunolabelled for GFP (green) and NeuN 
(red). All white arrows point to GFP+/NeuN- cells. GFP (green) is used to indicate EGFP and EYFP 
fluorescence. Scale bars: 20 µm (applied to all). 
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3.3 Analysis of reporter positive cells in the CNP-
Cre:ROSA26/EYFP line 
3.3.1 EYFP expression in mature oligodendrocytes in gray and white 
matter forebrain 
Double immunolabellings of NG2-GFP and CC1-GFP were performed to determine if 
CNP-Cre mediated EYFP expression was observed in oligodendrocytes of the P10 and 
P30 CNP-Cre:ROSA26/EYFP line.  
The absolute number of EYFP+ cells per 1x10-3 mm3 increased significantly from P10 
to P30, both in the dorsal cortex (P10, 23 ± 3.6 per 1x10-3 mm3; P30, 50 ± 6 per 1x10-3 
mm3; p < 0.05) and corpus callosum (P10, 44 ± 6 per 1x10-3 mm3; P30, 148 ± 20 per 
1x10-3 mm3; p < 0.05) (Figure 18E). 
NG2-GFP co-labellings 
In the dorsal cortex, the fraction EYFP+ cells that were NG2 cells decreased from 0.66 
± 0.13 (total of 358 EYFP+ cells, n=4 animals) at P10 to 0.3 ± 0.03 (total of 358 EYFP+ 
cells, n=4 animals) at P30 (Figure 18A, white arrowheads; F).  
Similarly, in the corpus callosum, the proportion of EYFP+ cells that were NG2+ de-
creased from 0.28 ± 0.05 (total of 418 EYFP+ cells, n=4 animals) at P10 to 0.07 ± 0.02 
(total of 853 EYFP+ cells, n=4 animals) at P30 (Figure 18C,F). This decrease in the 
fraction of EYFP+ cells that were NG2+ from P10 to P30 is indicative of differentia-
tion. 
CC1-GFP co-labellings 
The fraction of EYFP+ cells that were CC1+ mature oligodendrocytes increased from 
P10 to P30 in the dorsal cortex (P10, 0.05 ± 0.01, total of 137 EYFP+ cells; P30, 0.24 ± 
0.02, total of 592 EYFP+ cells; p < 0.05) and corpus callosum (0.65 ± 0.03, total of 318 
EYFP+ cells; P30, 0.87 ± 0.01, total of 991 EYFP+ cells; p < 0.05). However, it is 
noteworthy that there was an accumulation of EYFP+ cells that were neither NG2+ 
OPCs nor CC1+ oligodendrocytes (Figure 18A-B, white and yellow arrows; F).  
Therefore, although CNP-Cre mediated EYFP expression was observed in mature oli-
godendrocytes, there was a large population of EYFP+ cells which were distinct neither 
NG2+ OPCs or CC1+ oligodendrocytes and remained uncharacterised.  
3 Results 57 
 
 
 
Figure 18. EYFP expression in mature oligodendrocytes in the CNP-Cre:ROSA26/EYFP line. A-D, 
Frontal sections through the Dorsal Cortex (A,B) and Corpus Callosum (C,D) of P10 and P30 CNP-
Cre:ROSA26/EYFP mice, immunolabelled for GFP (green), NG2 (red) (A,C) and GFP (green), CC1 
(red) (B,D). All white arrowheads point to GFP+/NG2+ cells. All white arrows point to GFP+/NG2- 
cells. All yellow arrowheads point to GFP+/CC1+ cells. All yellow arrows point to GFP+/CC1- cells. 
GFP (green) is used to indicate EGFP and EYFP fluorescence. Scale bars: 10 µm (applied to all). E, His-
tograms showing absolute numbers of EYFP+ cells in the Dorsal Cortex and Corpus Callosum at postna-
tal days 10 and 30 in the CNP-Cre:ROSA26/EYFP line. F-G, Histograms showing fractions (F) and abso-
lute numbers (G) of reporter positive cells that were NG2+ OPCs and CC1+ mature oligodendrocytes in 
the Dorsal Cortex and Corpus Callosum at postnatal days 10 and 30 in the CNP-Cre:ROSA26/EYFP line. 
Error bars indicate SEM (±). Student’s unpaired t-test used to indicate significant difference, * indicates p 
< 0.05. n.s, non-significant. D.Ctx, Dorsal Cortex; CC, Corpus Callosum. 
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The next set of experiments that I undertook in this study, were to ascertain the pheno-
type of these non-oligodendroglial lineage reporter positive cells in the CNP-
Cre:ROSA26/EYFP line.  
3.3.2 EYFP expression in a small subset of astrocytes in the early 
postnatal and adult ventral cortex  
Analysis of early postnatal brains (P6 and P10) of CNP-Cre:ROSA26/EYFP mice sur-
prisingly revealed EYFP+ cells with astrocytic morphology and GFAP immunoreactiv-
ity, especially in the ventral forebrain (Figure 19C,C´; arrowheads). The fraction of 
EYFP+ cells that displayed GFAP immunoreactivity was 0.09 ± 0.01 (total of 526 
EYFP+ cells, n=8 animals).  
In the ventral cortex region of adult P30 mice, a greater proportion of EYFP+ astro-
cytes: 0.12 ± 0.02 (total of 179 EYFP+ cells, n=4 animals) were found (Figure 19A, 
arrowhead; D). In the P30 fimbrae (Figure 19B, arrowhead; D), a very miniscule frac-
tion of GFAP+ fibrous astrocytes among EYFP+ cells were encountered: 0.01 ± 0.004 
(total of 508 EYFP+ cells, n=4 animals). Also observed were EYFP+ GFAP+ cells that 
made end feet projections onto neighbouring blood vessels, a characteristic feature of 
astrocytes.  
It is important to point out that I observed a few, 6 out of 526 EYFP+ cells in the ventral 
forebrain regions, with a typical bushy morphology characteristic of astrocytes: large 
soma and asymmetrically radiating processes that consist of several primary thick proc-
esses, from which emanate multiple smaller collateral branching secondary processes. 
However, these cells lacked GFAP immunoreactivity.  
The fraction of GFAP+ astrocytes that were EYFP+ in the P30 ventral cortex was 0.13 
± 0.01 (total of 155 GFAP+ astrocytes, n=4 animals). 
Hence, the data presented here suggests that a small subset of GFAP+ astrocytes in the 
ventral forebrain is generated from precursor cells labelled by CNP-Cre mediated re-
combination in the CNP-Cre:ROSA26/EYFP animals. 
However, this fraction of EYFP+ cells being GFAP+ astrocytes was small and could not 
account for the large fraction of “unidentified” EYFP+ non-NG2+, non-CC1+ cells pre-
sent in the P10 and P30 gray matter; therefore further experiments were performed to 
characterise these cell types. 
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Figure 19. EYFP expression in a subset of ventral forebrain astrocytes in the CNP-
Cre:ROSA26/EYFP line. A,B, Frontal sections through the Ventral Cortex (A) and Fimbrae (B) of P30 
CNP-Cre:ROSA26/EYFP mice double-immunolabelled for GFP (green) and GFAP (red). C, Frontal 
sections through the Ventral Cortex of P6 CNP-Cre:ROSA26/EYFP mice double-immunolabelled for 
GFP (green) and GFAP (red). C´depicts the boxed are in C at higher magnification. All arrowheads point 
to GFP+/GFAP+ cells. GFP (green) is used to indicate EGFP and EYFP fluorescence. Scale bars: 20 µm 
(applied to all). D, Fraction of EYFP+ cells that were GFAP+ in the given regions of CNP-Cre:Z/EG and 
CNP-Cre:ROSA/EYFP lines. Error bars indicate SEM (±). Student’s unpaired t-test used to indicate sig-
nificant difference, * indicates p < 0.05. D.Ctx, Dorsal Cortex; CC, Corpus Callosum; Fim, Fimbrae; 
V.Ctx, Ventral Cortex. 
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3.3.3 EYFP expression in a large subpopulation of neurons in the adult 
dorsal, ventral and piriform cortex 
A large number of reporter positive neurons were observed in CNP-Cre:ROSA26/EYFP 
mice.  
 
 
 
Figure 20. EYFP expression in a subset of neurons in the dorsal, ventral and piriform cortices of 
the adult CNP-Cre:ROSA26/EYFP line. A-C, Frontal sections through the Dorsal Cortex (A), Ventral 
Cortex (B) and Piriform Cortex (C) of P30 CNP-Cre:ROSA26/EYFP mice double-immunolabelled for 
GFP (green) and NeuN (red). All white arrows point to GFP+/NeuN- cells. All yellow arrowheads point 
to GFP+/NeuN+ cells. GFP (green) is used to indicate EGFP and EYFP fluorescence. Scale bars: 20 µm 
(applied to all). D, Fraction of EYFP+ cells that were NeuN+ neurons in given regions of the CNP-
Cre:Z/EG and CNP-Cre:ROSA/EYFP mice. Error bars indicate SEM (±). Two-way Anova with Bon-
ferroni post-hoc test used to indicate significant difference. * indicates p < 0.0001 for all three cortices. 
D.Ctx, Dorsal Cortex; V.Ctx, Ventral Cortex; Piri.Ctx, Piriform Cortex. 
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The fraction of EYFP+ cells being NeuN+ mature neurons was 0.55 ± 0.07 (total of 607 
EYFP+ cells, n=4 animals), 0.37 ± 0.08 (total of 188 EYFP+ cells, n=4 animals) and 0.7 
± 0.05 (total of 353 EYFP+ cells, n=4 animals) in the dorsal (Figure 20A, arrowheads; 
D), ventral (Figure 20B, arrowheads; D) and piriform cortices (Figure 20C, arrowheads; 
D) respectively. Intriguingly, no EYFP+ neurons were observed in the CA1 hippocam-
pal region and the dentate granule layer, suggestive of region specificity in neurogene-
sis.  
The fraction of NeuN+ neurons that were EYFP+ was 0.23 ± 0.05 (total of 1462 NeuN+ 
neurons, n=4 animals) in the dorsal cortex, 0.08 ± 0.02 (total of 868 NeuN+ neurons, 
n=4 animals) in the ventral cortex and 0.22 ± 0.04 (total of 1264 NeuN+ neurons, n=4 
animals) in the piriform cortex. Therefore these results indicate that large subset of neu-
rons in the dorsal and piriform cortices were generated from precursors cells labelled by 
CNP-Cre mediated recombination. 
The proportion of EYFP+ cells that were NeuN+ mature neurons in the CNP-
Cre:ROSA26/EYFP line can be assumed to represent the large subset of NG2 and CC1 
negative reporter positive cells observed in the adult cortex (section 3.3). 
3.3.3.1 Age dependent distribution of EYFP+ neurons 
In the CNP-Cre:ROSA26/EYFP animals, where a large subset of EYFP+ neurons had 
been observed in the dorsal and piriform cortices, the age dependence of reporter posi-
tive neuronal distribution was determined at varying time points ranging from P10 to 
P30. Subsequent to double-immunolabellings for GFP and NeuN to identify reporter 
positive mature neurons, GFP+NeuN+ cells in the postnatal days 10, 12, 15, 17, 22, 25 
and 30 dorsal cortex and piriform cortices were counted. Animals were grouped in the 
P10-P12, P15-P17 and P22-P30 age groups. In the dorsal cortex, at P10-P12 age range 
there were ~7 ± 1.6 per 1x10-3 mm3 (n=3 animals) GFP+NeuN+ neurons. There was no 
significant difference in the number of EYFP+NeuN+ neurons present at the P15-P17 
time point (9.3 ± 1.1 per 1x10-3 mm3; n=4 animals). There were 15.5 ± 3.4 per 1x10-3 
mm3 (n=5 animals) EYFP+NeuN+ neurons in the P22-P30 age group and this did not 
represent a significant increase from the number of reporter positive neurons at P10-P12 
or P15-P17 (Figure 21A). Similarly in the piriform cortex, the number of EYFP+NeuN+ 
cells at P22-P30 were 14.2 ± 3.3 per 1x10-3 mm3 (n=5 animals). These were not signifi-
cantly different in numbers from the EYFP+NeuN+ neurons present at either P10-P12 
or P15-P17 time points (Figure 21B). These findings demonstrate that there is no sig-
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nificant increase in the number of reporter positive neurons from P10 to P30 in the dor-
sal and piriform cortices.  
 
 
Figure 21. Age dependent distribution of EYFP+ neurons in the CNP-Cre:ROSA26/EYFP line. 
A,B, Absolute number of EYFP+/NeuN+ neurons at postnatal age groups P10-P12, P15-P17 and P22-
P30, in the Dorsal Cortex (A) and Piriform Cortex (B). Error bars indicate SEM (±). One-way Anova 
with Tukey’s post-hoc test used to indicate significant difference. D.Ctx, Dorsal Cortex; Piri.Ctx, Piri-
form Cortex; n.s, non-significant. 
3.4 Analysis of neurogenic time point 
Having observed reporter expression by neurons in the CNP-Cre:ROSA26/EYFP line, it 
was essential to determine if they were generated postnatally from mitotic CNP-
expressing cells or if there was an embryonic source of these EYFP labelled neurons, 
that was also labelled by the CNP-Cre knock-in approach. As a pilot study to ascertain 
the neuronogenic time point in the CNP-Cre:ROSA26/EYFP transgenic line, I decided 
to undertake BrdU pulse chase labelling at embryonic ages to first examine the time 
point of neurogenesis in wildtype mice and establish the BrdU pulse chase protocols 
and immunolabellings. 
3.4.1 A large subset of neurons in the adult dorsal cortex co-label BrdU 
upon E16 pulse-chase 
Upon BrdU injections to wild type mice at E16, double-immunolabellings for NeuN and 
BrdU were performed at P30, to examine the proportion of BrdU positive cells among 
NeuN positive mature neurons. 
I concentrated the analysis in the layer II/III region of the cortices, as this was the layer 
where I had observed the highest number of reporter positive neurons in the CNP-Cre 
expressing mouse line. In the dorsal cortex, the fraction of NeuN positive cells that were 
BrdU positive was 0.67 ± 0.003 (total of 795 NeuN+ neurons, n=2 animals) (Figure 
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22A, arrowheads; C). However, the fraction of neurons that co-labelled BrdU in the 
ventral and piriform cortices was 0.04 ± 0.001 (total of 382 NeuN+ neurons, n=2 ani-
mals) (Figure 22B,C) and 0.04 ± 0.002 (total of 472 NeuN+ neurons, n=2 animals) re-
spectively. 
Having established postnatal and embryonic BrdU administration protocols in wildtype 
mice, targeting proliferating postnatal populations and dorsal cortex neurons respec-
tively, I then undertook BrdU pulse chase labelling in CNP-Cre:ROSA26/EYFP mice to 
ascertain the time point of neurogenesis of the observed EYFP+ neurons.  
 
 
 
Figure 22. Time point of neurogenesis. A,B, Frontal sections through the Dorsal Cortex (A) and Ventral 
Cortex (B) of P30 wild type mice double immunolabelled for NeuN (red) and BrdU (green). All arrow-
heads point to NeuN+/BrdU+ mature neurons. Scale bars: 20 µm (applied to all). C, Fraction of NeuN+ 
neurons being BrdU+ at P30, upon E16 BrdU administration. All error bars indicate SEM (±). One-way 
Anova with Tukey’s post-hoc test used to indicate significant difference. * indicates p < 0.05. n.s, non-
significant; D.Ctx, Dorsal Cortex; V.Ctx, Ventral Cortex; CC, Corpus Callosum; Fim, Fimbrae.  
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3.5 Evidence of neurogenesis from embryonic EYFP+ 
precursors 
In order to determine the time point of extensive neurogenesis observed in the ventral 
and piriform cortices of CNP-Cre:ROSA26/EYFP mice, BrdU labelling assays were 
performed at both postnatal and embryonic time points. The rationale here being that if 
EYFP+ neurons were derived from proliferation and differentiation of reporter positive 
precursors at a certain postnatal or embryonic time point, it is expected that they would 
incorporate BrdU label from their progenitor cell. 
3.5.1 EYFP+ neurons in the ventral and piriform cortex co-label BrdU 
upon E12.5 pulse-chase 
With E12.5 BrdU administration via oral gavage twice a day, four hours apart (Figure 
23A), a significant population of EYFP+ neurons that were BrdU+ were observed in the 
ventral and piriform cortices at P30 (Figure 23C,D, arrowheads). The fraction of EYFP 
neurons being BrdU+ was 0.63 ± 0.1 (total of 468 EYFP+ neurons, n=6 animals) and 
0.8 ± 0.04 (total of 250 EYFP+ neurons, n=6 animals) in the piriform and ventral cortex 
respectively (Figure 23I).  
However, in the dorsal cortex this fraction was only 0.03 ± 0.01 (total of 393 EYFP+ 
neurons, n=6 animals) (Figure 23B, arrowhead; I); this low fraction of EYFP+ neurons 
that were BrdU labelled can be explained when seen in light of BrdU labellings in wild-
type mice (see section 3.4.1) and other studies, where it was shown that in the dorsal 
cortex neurogenesis predominantly occurs around E16 (Bayer and Altman, 1990). 
3.5.2 Lack of evidence for postnatal neurogenesis from EYFP+ 
precursors 
In the postnatal BrdU labelling strategy, P10 CNP-Cre:ROSA26/EYFP mice were ad-
ministered BrdU via 2 i.p injections, 12 hours apart for four days (Figure 23E). P32 
immunohistochemical analysis of BrdU administered mice revealed that almost no 
EYFP+ neurons were BrdU+; with fraction of EYFP+ neurons that were BrdU+ being 0 
both in the dorsal (total of 711 EYFP+ cells, n=4 animals) and piriform cortices (total of 
387 EYFP+ cells, n=4 animals), and in the ventral cortex being 0.01 ± 0.01 (total of 355 
EYFP+ cells, n=4 animals) (Figure 23F-H, arrows; I). Taken together these data suggest 
that in the ventral and piriform cortices, progenitors labelled by the CNP-Cre knock-in 
strategy serve as neuronal precursors during the early embryonic development. 
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Figure 23. Neurogenesis from embryonic progenitors labelled by CNP-Cre mediated recombina-
tion. A, BrdU administration strategy to E12.5 CNP-Cre:ROSA26/EYFP mice via oral gavage. B-D, 
Frontal sections through the Dorsal Cortex (B), Ventral Cortex (C) and Piriform Cortex (D) of BrdU 
administered animals at P30 double immunolabelled for GFP (green) and BrdU (red). E, BrdU admini-
stration strategy to postnatal CNP-Cre:ROSA26/EYFP mice via i.p injections from P10-P13. F-H, Frontal 
sections through the Dorsal Cortex (F), Ventral Cortex (G) and Piriform Cortex (H) of BrdU injected 
animals at P32 double immunolabelled for GFP (green) and BrdU (red). All arrowheads point to 
GFP+/BrdU+ neurons. All arrows point to GFP+/BrdU- neurons. GFP (green) is used to indicate EYFP 
fluorescence. Scale bars: 20 µm (applied to all). I, Fraction of EYFP+ neurons that were BrdU+ at both 
embryonic and postnatal BrdU administration time points in the given regions. Error bars indicate SEM 
(±). Two-way Anova with Bonferroni post-hoc test used to indicate significant difference. * indicates p < 
0.0001 for the Ventral and Piriform Cortices. n.s, non-significant; adm, administration; i.p, intraperito-
neal; D.Ctx, Dorsal Cortex; V.Ctx, Ventral Cortex; Piri.Ctx, Piriform Cortex. 
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3.5.3 Absence of BrdU labelling in EYFP+ OPCs upon E12.5 pulse-chase 
Having found evidence with the BrdU pulse-chase experiments that embryonic CNP-
Cre labelled precursor cells generate neurons, it was imperative to rule out the possibil-
ity that the BrdU+ neurons observed at P30 (after E12.5 BrdU injection) were the result 
of generation from postnatal reporter positive NG2 cells; which could have incorporated 
the BrdU label as they are generated from embryonic oligodendroglial lineage precursor 
cells. For this triple-immunolabellings of NG2, GFP and BrdU were performed on ani-
mals that had received BrdU at E12.5 and sacrificed at P30.  
 
 
Figure 24. Reporter positive OPCs are not labelled by E12.5 BrdU pulse chase. A, Frontal sections 
through the Ventral Cortex (A) and Piriform Cortex (B) of P29 CNP-Cre:ROSA26/EYFP animals that 
were administered BrdU at E12.5 triple immunolabelled for GFP (green), NG2 (red) and BrdU (blue). All 
Arrows point to GFP+/NG2+/BrdU- cells. GFP (green) is used to indicate EYFP fluorescence. Scale bars: 
20 µm (applied to all). 
 
In the ventral and piriform cortices, the regions where a high fraction of reporter posi-
tive neurons showed co-labelling for BrdU (see Figure 23); I failed to report any 
NG2+GFP+ OPCs that displayed BrdU immunoreactivity. Out of 135 NG2+GFP+ cells 
analysed, each in the piriform cortex and ventral cortex of 50 µm thick frontal sections 
from four animals, no BrdU positivity was observed in any of them (Figure 24A-B). 
While the results of this experiment indicate that neurons were primarily generated from 
embryonic CNP-Cre expressing precursors, rather than from postnatal NG2 cells; how-
ever other explanation for this are discussed in section 4.3. 
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Embryonic BrdU labelling experiments performed in this study had revealed an embry-
onic source of reporter positive neurons observed in the CNP-Cre:ROSA26/EYFP line; 
therefore the next set of experiments were dedicated to examining CNP-Cre mediated 
reporter expression in the CNP-Cre:ROSA26/EYFP lines at embryonic time points. 
CNP-Cre:Z/EG mice where I had not observed any reporter positive neurons (section 
3.2.3) were also examined for the presence of EGFP+ cells at embryonic ages. 
3.6 EYFP expression in non-oligodendroglial lineage cells in 
the embryonic forebrain 
It has been already mentioned (in section 1.2.4), that in situ hybridisation studies 
showed the presence of Cnp expression as early as E12.5; as reporter expression had 
been thus far determined only in the postnatal ages in the CNP-Cre:Z/EG and CNP-
Cre:ROSA26/EYFP transgenic lines, the obvious next step was to verify the earliest 
time point of reporter expression. Thus, to this end the CNP-Cre:ROSA26/EYFP and 
CNP-Cre:Z/EG mice were analysed at embryonic ages.   
In the CNP-Cre:ROSA26/EYFP mice at embryonic time points, a large number of re-
porter positive cells were observed throughout the CNS. EYFP+ cells were found in the 
E18 ventricular and subventricular zones of the lateral ventricles and the cortex. Espe-
cially at the dorso-lateral and lateral ventricular wall, reporter positive cells appeared in 
small cohorts of columns and seemed to be migrating towards the pial surface (Figure 
25A-B, arrowheads). At E12.5 EYFP+ cells were observed at the cortical plate, ven-
tricular zone of the lateral ventricles and the ganglionic eminences; with expression lo-
calized at the anterior lateral ganglionic eminence (LGE) and a few scattered cells at the 
medial ganglionic eminence (MGE) (Figure 25F-G). 
Furthermore to examine the phenotype of these embryonic reporter positive CNP-Cre 
expressing cells, I decided to perform an NG2-GFP double-immunolabelling at E16. A 
large population of EYFP+ cells in the dorsal cortex and subventricular zone did not 
display antigenicity for NG2 (Figure 25C-D, yellow arrowheads). The proportions of 
EYFP+ cells that were NG2+ cells in the dorsal cortex and SVZ were significantly dif-
ferent at 0.14 ± 0.03 (total of 762 EYFP+ cells, n= 3 animals) and 0.04 ± 0.01 (total of 
1264 EYFP+ cells, n= 3 animals) (Figure 25C-D, white arrowheads; E) respectively. 
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Figure 25. CNP-Cre driven reporter expression in the embryonic forebrain. A,B, Frontal sections 
through the Dorsal Forebrain of E18 CNP-Cre:ROSA26/EYFP mice immunolabelled for GFP (green). 
White arrowheads point to column of GFP+ cells at the Ventricular Wall. C,D, Frontal sections through 
the Dorsal Cortex (C) and Subventricular Zone (D) of E16 CNP-Cre:ROSA26/EYFP mice double immu-
nolabelled with GFP (green) and NG2 (red). Boxed areas in C and D are shown at higher magnification in 
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Figure 25. (continued) C´and D´ respectively. All white arrowheads point to GFP+/NG2+ cells. All yel-
low arrowheads point to GFP+/NG2- cells. E, Fraction of EYFP+ cells that were NG2+ in the E16 CNP-
Cre:ROSA26/EYFP Dorsal Cortex and Subventricular Zone. Error bars indicate SEM (±). Student’s un-
paired t-test used to indicate significant difference, * indicates p < 0.05. F,G, Frontal sections through the 
Dorsal (F) and Ventral (G) Forebrains of E12.5 CNP-Cre:ROSA26/EYF mice immunolabelled with GFP. 
H, Frontal section through the Dorsal Forebrain of the E16 CNP-Cre:Z/EG mouse immunolabelled for 
GFP. GFP (green) is used to indicate EYFP fluorescence. Scale bars: 50 µm (applied to A,B,F-H); 20 µm 
(applied to C,D). CP, Cortical Plate; D.Ctx, Dorsal Cortex; LGE, Lateral Ganglionic Eminence; MGE, 
Medial Ganglionic Eminence; SVZ, Subventricular Zone; V, Ventricle. 
At the lateral ventricular wall only 4 out of 430 EYFP+ cells (n=2 animals) examined at 
the lateral ventricular wall exhibited NG2 immunoreactivity.  
In contrast, I failed to observe any reporter positivity in the forebrain regions of the ven-
tricular zone, subvbentricular zone and cortex in the embryonic CNP-Cre:Z/EG line 
(Figure 25H). Frontal sections through entire forebrain were devoid of EGFP+ cells 
(n=4 animals). 
 Together, these findings indicate that a difference in the time point of appearance of 
reporter positive cells was observed between CNP-Cre:ROSA26/EYFP and CNP-
Cre:Z/EG mice, with EYFP expression starting from early embryonic ages, contrasting 
with the postnatal detection of EGFP+ cells.  
3.7 EYFP expression in radial glia-like cells in the embryonic 
ventricular zone  
Having observed numerous EYFP+ cells at E16.5, I sought to elucidate the phenotype 
of these cell types. Brain Lipid Binding Protein (BLBP) is a hydrophobic ligand binding 
protein and is expressed exclusively in radial glia and astrocytes throughout the devel-
oping CNS (Feng et al., 1994).  
It has been well established that during embryonic development BLBP+ radial glial 
cells serve as neural progenitors and generate neurons as well as glial cells- both oli-
godendrocytes and astrocytes (Kriegstein and Götz, 2003; Malatesta et al., 2008; 
Kriegstein and Alvarez-Buylla, 2009). 
To this end, I asked whether the EYFP+ precursors observed during embryonic stages 
displayed phenotypic properties reminiscent of radial glial cells. For this double immu-
nolabellings with GFP and BLBP antibodies were performed. At E16, EYFP+ cells with 
typical radial glial morphology, a spindle-shaped elongated cell body and bipolar proc-
esses were found predominantly at the VZ seemingly migrating away towards the pial 
surface. 
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Figure 26. Radial glial phenotype of embryonic reporter positive cells labelled by CNP-Cre medi-
ated recombination. A,B, Frontal sections through the Ventricular Zone (A) and Dorsal Cortex (B) of 
E16 CNP-Cre:ROSA26/EYFP mice double immunolabelled for GFP (green) and BLBP (red). All arrow-
heads point to GFP+/BLBP+ cells. GFP (green) is used to indicate EYFP fluorescence. Scale bars: 20 µm 
(applied to all). C, Fraction of EYFP+ cells being BLBP+ in the Ventricular Zone and Dorsal Cortex of 
CNP-Cre:ROSA26/EYFP mice. Error bars indicate SEM (±). Student’s unpaired t-test used to indicate 
significant difference. n.s, non-significant; VZ, Ventricular Zone; D.Ctx, Dorsal Cortex. 
In the E16 CNP-Cre:ROSA26/EYFP mice significant co-labelling was observed the 
fraction of EYFP+ cells co-expressing the radial glial marker BLBP was 0.36 ± 0.1 (to-
tal of 339 EYFP+ cells, n=3 animals) and 0.28 ± 0.06 (total of 435 EYFP+ cells, n=3 
animals) in the dorsal cortex and ventricular zone respectively (Figure 26A-B, arrow-
heads; C).  
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3.8 Absence of CNPase protein in EYFP+ OPCs 
In the CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP lines, Cre-mediated reporter ex-
pression in OPCs is brought about by the activity of the Cnp promoter; thereby indicat-
ing that the Cnp gene is actively transcribed in these EGFP+ or EYFP+ OPCs. In the 
next set of experiments, I sought to investigate whether the Cnp gene product- CNPase 
was expressed in postnatal reporter positive NG2-expressing OPCs. Immunolabellings 
for CNPase, GFP and NG2 revealed that reporter positive NG2 cells in the dorsal cortex 
and subcortical white matter regions did not express the CNPase protein. This is in con-
junction with studies that have shown that CNP expression occurs when OPCs enter 
terminal differentiation stages preceding myelination (Amur-Umarjee et al., 1990; 
Bansal and Pfeiffer, 1985). 
 
 
Figure 27. Absence of CNPase expression in reporter positive NG2 cells. A-D, Frontal sections 
through the Subcortical white matter (A,C) and Dorsal Cortex (B,D) of P10 CNP-Cre:Z/EG (A,B) and 
CNP-Cre:ROSA26/EYFP (C,D) mice triple-immunolabelled for GFP (green), CNP (red) and NG2 (blue). 
All white arrowheads point to NG2+/GFP-/CNP- cells. All yellow arrowheads point to 
NG2+/GFP+/CNP- cells. All white arrow points to NG2-/GFP-/CNP+ cell. Yellow arrowhead points to 
NG2-/GFP+/CNP+ cell. GFP (green) is used to indicate EYFP fluorescence. Scale bars: 20 µm (applied 
to all). SCWM, Subcortical white matter. 
In the P10 CNP-Cre:Z/EG mice, 0 out of 28 NG2+EGFP+ cells in the dorsal cortex 
expressed the CNP protein (n=2 animals). Similarly the fraction of NG2+EGFP+ cell 
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being CNPase positive in the subcortical white matter was also 0 (total of 9 
NG2+EGFP+ cells) (Figure 27A-B, yellow arrowheads). 
In the P10 CNP-Cre:ROSA26/EYFP line, 0 out of 89 NG2+EYFP+ cells and 0 out of 
80 NG2+EYFP+ cells each in the subcortical white matter and dorsal cortex respec-
tively, expressed CNPase (n=3 animals) (Figure 27C-D, arrowheads). A few i.e. ~12 
reporter positive displaying CNPase immunoreactivity (total of 473 EYFP+ cells, n=3 
animals) were observed in the white matter, but these cells were negative for NG2, sug-
gesting that these were more differentiated oligodendroglial lineage cells (Figure 27C, 
yellow arrow).  
Taken together, these results indicate that a clear difference in CNP-Cre driven reporter 
expression and CNP protein expression was observed in OPCs. 
3.9 Unspecific EYFP expression with postnatal Cre-dependent 
EYFP virus transfection 
The experiments performed thus far provided substantial proof that precursor cells la-
belled by the CNP-Cre knock-in approach served as a precursor pool for neuronal phe-
notypes during embryonic time points. CNP-Cre mediated reporter expression was also 
observed in embryonic radial-glia like cells. Therefore, the next set of experiments were 
designed to “bypass” these embryonic precursor cells, thus selectively labelling only the 
postnatal CNP-Cre expressing cell population: presumably oligodendroglial lineage 
restricted precursors, to ascertain their progeny. This was done by employing a Cre-
dependent EYFP virus transfection approach (see Methods section 2.7). 
In order to first standardize the virus injection protocol, a Cre-independent approach 
was adopted. I administered a CMV-Venus virus construct in varying volumes and fre-
quencies intraventricularly. From the transfection protocols: injections of 1 µl once a 
day for one day (1µl x 1 / 1 day) (n= 8 animals), 3 µl x 2 / 2 days (n= 6 animals) and 3 
µl x 2 / 1 day (n= 6 animals), the best transfection rate depicted by the number of re-
porter positive cells was observed in the protocol with 3 µl injections of the virus twice 
a day for 1 day (Figure 28A,B,C).  
The Cre-dependent EYFP virus was injected in the ventricles of P3 CNP-Cre +/-:Z/EG-/- 
mice (n=4 animals) and there was a widespread transfection in the hippocampus, dorsal 
cortex and ventricles. A large number of oligodendrocytes and OPCs were in the cortex 
and corpus callosum. 
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Figure 28. Cre-dependent EYFP virus transfection strategy to follow OPC lineage. A-C, Frontal 
sections through the Dorsal Cortex of wildtype mice with CMV-Venus virus construct injections 4dpi (1 
µl per day for one day) (A), 1dpi (3 µl twice a day for two days) (B), 1dpi (3 µl twice a day for one day) 
(C) immunolabelled for GFP. D-F, Frontal section 3 dpi of Cre-dependent EYFP construct (1 µl per day 
for one day) through the Hippocampus (D), Dorsal Cortex (E) and 14 dpi through the Hippocampus (F) of 
CNP-Cre:Z/EG mice immunolabelled for GFP. G-I, Frontal section 7 dpi of Cre-dependent EYFP con-
struct (1 µl per day for one day) through the Striatum (G), and 15 dpi through the Dorsal Cortex (H), 
Striatum (I) of Wildtype mice immunolabelled for GFP. GFP (green) is used to indicate EYFP fluores-
cence. Scale bars: 50 µm (applied to all). dpi, days post injection. 
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Also, neurons and astrocytes were observed in the hippocampus and dorsal cortex, with 
few premyelinating oligodendrocytes in the striatum at 3 dpi (n=2 animals) and 14 dpi 
(n=2 animals) (Figure 28D,E,F).  
Intrigued by the sheer number of transfected cell types, I then decided to examine the 
Cre dependence of the Cre-dependent EYFP virus construct; therefore P2 wild type 
mice (n=10 animals) were injected with the Cre-dependent EYFP virus. Since reporter 
positivity is controlled by Cre recombination and with Cre recombinase being absent in 
this strategy, I expected to find no EYFP+ cells upon transfection. On the contrary, at 7 
dpi (n=2 animals) I observed astrocytes in the striatum (~2 cells in 50 µm frontal sec-
tion) (Figure 28G) as well as neurons in the dorsal cortex (1-2 cells in 50 µm frontal 
section) (Figure 28H). At 15 dpi (n=2 animals) around 15-20 EYFP+ neurons were seen 
in the region spanning the dorsal cortex all the way down till the ventral cortex (Figure 
28I) and 8-10 reporter positive astrocytes were observed in the striatum. 
With Cre-dependent EYFP virus injections in wildtype mice, reporter positive neurons 
and astrocytes were observed at locations in the dorsal, piriform and ventral cortices, in 
numbers that were comparable to those observed in the CNP-Cre:ROSA26/EYFP line. 
Thus, with this approach it would not be possible to determine if EYFP positivity ob-
served in neurons and astrocytes was due to “leaky Cre” activity or were the progeny of 
CNP-Cre expressing cells; thereby making this approach un-usable. 
3.10 EYFP expression in radial glia-like cells and neurons in 
the NG2creERTMBAC:ROSA26/EYFP line  
In previous experiments with the CNP-Cre:ROSA26/EYFP line, I observed reporter 
expression not restricted exclusively to NG2 cells but extending to a more widespread 
population of early neural stem cells (section 3.7). Therefore having labelled precursor 
cells not belonging exclusively to the oligodendroglial lineage with the CNP-Cre knock 
in, it was imperative to adopt an experimental strategy to label only OPCs to answer the 
question if OPCs have a neuronogenic potential. The Tamoxifen-inducible 
NG2creERTMBAC transgenic mice were crossed with the ROSA26/EYFP Cre reporter, 
to accomplish lineage tracing of purely oligodendroglial lineage precursor cells.  
Numerous reporter positive cells were observed in both gray and white matter regions 
of E19.5 NG2creERTMBAC:ROSA26/EYFP mice subsequent to Cre induction at E16.5. 
NG2-GFP immunolabelling revealed a miniscule population of reporter positive cells 
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that were immunoreactive for NG2 throughout the entire ventral and dorsal forebrains. 
It should be remembered that at ~E11.5 upon specification in ganglionic eminences 
(section 1.2.3.2), OPCs acquire NG2 expression around ~E15 as they begin migrating 
from germinal zones (Nishiyama et al., 1996, 2007). The proportion of EYFP+ cells that 
were NG2 positive in the ventricular zone was only 0.07 ± 0.04 (total of 283 EYFP+ 
cells, n=3 animals) (Figure 29A, arrows).  
Numerous EYFP+ cells seen at the lateral, dorsal and ventral ventricular wall, often 
found in clusters seen to be migrating away to the pial surface and depicting a typical 
radial glial morphology. Apart from morphological characterisation, BLBP-GFP co-
immunolabellings to identify the radial glial phenotype of EYFP+ cells revealed that the 
proportion of EYFP+ cells which were BLBP+ radial glia-like cells was 0.16 ± 0.02 
(total of 213 EYFP+ cells, n=3 animals) in ventricular zone (Figure 29B, arrowhead). It 
is worth mentioning that at this embryonic time point, a considerable subset of reporter 
positive cells reminiscent of a typical neuronal morphology were observed in the dorsal, 
ventral and piriform cortices.  
 
Figure 29. Phenotype of EYFP+ cells in the E19.5 NG2creERTMBAC:ROSA26/EYFP line (E16.5 
TMX administration). A, Frontal sections through the Ventricular Zone of E19.5 
NG2creERTMBAC:ROSA26/EYFP mice that were administered Tamoxifen at E16.5, immunolabelled for 
GFP (green), NG2 (red). All arrows point to GFP+/NG2- cells. B, Frontal sections through the Ventricu-
lar Zone of E19.5 NG2creERTMBAC:ROSA26/EYFP mice that were administered Tamoxifen at E16.5, 
immunolabelled for GFP (green), BLBP (red). All arrows point to GFP+/BLBP- cells. All arrowheads 
point to GFP+/BLBP+ cells. VZ, Ventricular Zone. 
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Figure 30. Extensive cortical neurogenesis in NG2creERTMBAC:ROSA26/EYFP line. A-C, Frontal 
sections through the Dorsal (A), Ventral (B) and Piriform (C) cortices of P30 
NG2creERTMBAC:ROSA26/EYFP mice that were administered Tamoxifen at E16.5, double-
immunolabelled for GFP (green) and NeuN (red). All arrows point to GFP+/NeuN- cells. All arrowheads 
point to GFP+/NeuN+ cells. GFP (green) is used to indicate EGFP and EYFP fluorescence. Scale bars: 20 
µm (applied to all). D, Fraction of EYFP+ cells that were NeuN+ in the Dorsal, Ventral and Piriform 
Cortices of P30 NG2creERTMBAC:ROSA26/EYFP mice that were administered Tamoxifen at E16.5. 
Error bars indicate SEM (±). One-way Anova with Tukey’s post-hoc test used to indicate significant 
difference. * indicates p < 0.05. n.s, non-significant; D.Ctx, Dorsal Cortex; V.Ctx, Ventral Cortex; Pi-
ri.Ctx, Piriform Cortex. 
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Next, NG2creERTMBAC:ROSA26/EYFP double transgenic mice that were adminis-
tered Tamoxifen at late embryonic day E16.5, were analysed with GFP-NeuN double 
immunolabellings at P30 to inspect the occurrence of reporter positive cells that co-
labelled NeuN.  
At P30, a considerable population of EYFP+ cells with a characteristic neuronal mor-
phology: large soma, fine dendritic processes and a long axon; were seen primarily in 
the dorsal, ventral and piriform cortices. These reporter positive neurons also displayed 
immunoreactivity for the mature neuronal marker NeuN (Mullen et al., 1992). The pro-
portion of NeuN+ neurons among reporter positive cells in the dorsal, ventral and piri-
form cortex was 0.74 ± 0.04 (total of 458 EYFP+ cells, n=3 animals) (Figure 30A, ar-
rowheads; D), 0.42 ± 0.1 (total of 264 EYFP+ cells, n=3 animals) (Figure 30B, arrow-
heads; D) and 0.54 ± 0.04 (total of 265 EYFP+ cells, n=3 animals) (Figure 30C, arrow-
heads; D) respectively.  
Reporter positive neurons were also seen, although in considerably fewer numbers in 
the CA3 region of the hippocampus of the adult NG2creERTMBAC:ROSA26/EYFP 
animals.  
On the other hand, analysis of an adult (~P40) NG2creERTMBAC:ROSA26/EYFP ani-
mal which was administered Tamoxifen at P6, did not reveal any EYFP+ cells that rep-
resented a neuronal morphology throughout 50 µm thick frontal sections.  
3.11 Deletion of GluRB subunit in OPCs inhibits their 
proliferation 
The time period around the second to third postnatal week is the peak period of myeli-
nogenesis (Sturrock, 1980). Due to this reason OPCs were analysed at approximately 
this time point (2-3 weeks) to investigate the effect of GluRB deletion on the viability of 
OPCs, their cell number and proliferative potential. The dorsal cortex and corpus callo-
sum were chosen as representative regions of gray and white matter respectively. 
0.5 mg TMX was administered to NG2creERTMBAC:GluRB2lox/2lox:ROSA26/EYFP and 
NG2creERTMBAC:GluRBwt/wt:ROSA26/EYFP mice at P5 to P10 (single i.p injec-
tion/day for 1 or 3 days) for Cre induction. Importantly, it has been previously shown 
that with early postnatal TMX induction (similar to the one used in this study), majority 
of reporter positive cells were NG2 cells and a small fraction reporter positive cells 
were oligodendrocytes (Zhu et al., 2011). 
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Figure 31. Effect of GluRB removal on OPC cell number and proliferation. A,C, Frontal sections 
through the Dorsal Cortex (A) and Fimbrae (C) of Control: GluRBwt/wt mice immunolabelled for GFP 
(green) and BrdU (red). B,D, Frontal sections through the Dorsal Cortex (B) and Fimbrae (D) of Knock-
out: GluRB2lox/2lox mice immunolabelled for GFP (green) and BrdU (red). All arrowheads point to 
GFP+/BrdU+ cells. GFP (green) is used to indicate EYFP fluorescence. Scale bars: 20 µm (applied to 
all). E-F, Absolute number of EYFP+ cells in the Dorsal Cortex (E) and Fimbrae (F) of GluRBwt/wt and 
GluRB2lox/2lox mice. G-H, Fraction of EYFP+ cells being BrdU+ in the Dorsal Cortex (G) and Fimbrae (H) 
of GluRBwt/wt and GluRB2lox/2lox mice. Error bars indicate SEM (±). Student’s unpaired t-test used to indi-
cate significant difference, * indicates p < 0.05. n.s, non-significant. CTRL, Control; KO, Knockout. 
3 Results 79 
Subsequently, ~10 to 14 days post the last TMX injection, 300 mg/kg i.p injections of 
BrdU were given to these animals. These TMX and BrdU administered animals were 
then sacrificed three hours later and I further proceeded with GFP-BrdU double immu-
nolabellings on 50µm sections.  
GluRB KO mice i.e. animals in which the NG2 cells have presumably lost the GluRB 
subunit upon TMX induction were viable, survived into adulthood and did not exhibit 
any obvious behavioural alterations such as tremors or seizures associated with hypo-
myelination (Filley, 1998); although it must be stated that no behavioral tests were per-
formed. 
Next, absolute numbers of EYFP reporter positive cells were examined between the two 
experimental groups. No significant differences were observed in the cell density of 
EYFP+ cells per 1x10-3 mm3 in the dorsal cortex and fimbrae between GluRB KO and 
control groups (CTRL) (Figure 31E,F), suggesting that the survival of these cells re-
mains unaffected upon deletion of the GluRB subunit. In the dorsal cortex, the KO mice 
had ~20 ± 4 EYFP+ cells per 1x10-3 mm3 (n=7 animals) and the CTRL mice had ~12 ± 
2 EYFP+ cells per 1x10-3 mm3 (n=5 animals) (p=0.12, non-significant); while in the 
fimbrae, the KO mice had ~73 ± 13 EYFP+ cells per 1x10-3 mm3 (n=7 animals) and the 
CTRL mice had ~45 ± 11 EYFP+ cells per 1x10-3 mm3 (n=5 animals) (p=0.15, non-
significant).  
However, even within each experimental group the density of EYFP+ cells per 1x10-3 
mm3 will greatly depend on the TMX injection. Due to this reason and since OPCs rep-
resent the most proliferative postnatal cell population (Dawson, 2003; Psachoulia et al., 
2009), capable of compensatory mechanisms for reduction in their cell numbers 
(Kessaris et al., 2006); it was imperative to investigate for changes in the proliferative 
potential. 
In the dorsal cortex, the fraction of EYFP+ cells that were BrdU+ (Figure 31A,B, ar-
rowhead) was not significantly changed between the control and knockout groups 
(CTRL, 0.1 ± 0.06, total of 175 EYFP+ cells, n=5 animals and KO, 0.05 ± 0.01, total of 
420 EYFP+ cells, n=7 animals; p=0.11, non-significant) (Figure 31G).  
On the other hand, the fraction of EYFP+ cells being BrdU+ in the fimbrae was signifi-
cantly reduced in the fimbrae of the GluRB knockouts (Figure 31C,D, arrowhead; H) as 
compared to the control group (CTRL, 0.1 ± 0.03, total of 465 EYFP+ cells, n=5 ani-
mals; KO, 0.03 ± 0.01, total of 1018 EYFP+ cells, n=7 animals; p=0.03, significant).  
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3.12 Lack of evidence for change in OPC differentiation upon 
GluRB subunit deletion  
Synaptic input received by OPCs (Ziskin et al., 2007; Kukley et al., 2007) can also be 
speculated to regulate lineage progression vis-à-vis maturation and differentiation 
(Kukley et al., 2008; Etxeberria et al., 2010). 
 
 
Figure 32. Effect of GluRB removal on OPC differentiation. A,C, Frontal sections through the Dorsal 
Cortex (A) and Fimbrae (C) of Control: GluRBwt/wt mice immunolabelled for GFP (green) and NG2 (red). 
B,D, Frontal sections through the Dorsal Cortex (B) and Fimbrae (D) of Knockout: GluRB2lox/2lox mice 
immunolabelled for GFP (green) and NG2 (red). All arrowheads point to GFP+/NG2+ cells. All arrows 
point to GFP+/NG2- cells. GFP (green) is used to indicate EYFP fluorescence. Scale bars: 20 µm (ap-
plied to all). E, Fraction of EYFP+ cells being NG2+ in the CA1, Dorsal Cortex, Corpus Callosum and 
Fimbrae of GluRBwt/wt and GluRB2lox/2lox mice. Error bars indicate SEM (±). Two-way Anova with Bon-
ferroni post-hoc test used to indicate significant difference. n.s, non-significant. D.Ctx, Dorsal Cortex; 
CC, Corpus Callosum; Fim, Fimbrae. CTRL, Control; KO, Knockout. 
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To determine the contribution of the GluRB subunit to OPC maturation, 10 days to 20 
days old NG2creERTMBAC:GluR-B2lox/2lox:ROSA26/EYFP (KO group) and 
NG2creERTMBAC:GluR-Bwt/wt:ROSA26/EYFP (CTRL group) mice were given 0.5 mg 
Tamoxifen with 1 i.p injection per day for 3 days or 6 days to induce Cre recombina-
tion. Gray matter regions of CA1 and dorsal cortex, as well as white matter regions of 
fimbrae and corpus callosum were examined ~10 days after the last day of TMX induc-
tion with NG2-GFP double-immunolabellings to assess the population of NG2 cells 
among EYFP+ cells.  
Reporter positive cells with and without NG2 immunoreactivity (Figure 32A-D, arrow-
heads, arrows) were observed in all regions under examination. No differences were 
observed between the control and GluRB knockout experimental groups in the fraction 
of EYFP+ cells being NG2+ OPCs in the hippocampal CA1 (CTRL, 0.82 ± 0.03, total 
of 116 EYFP+ cells, n=5 animals; KO, 0.78 ± 0.06, total of 116 EYFP+ cells, n=7 ani-
mals; p > 0.05, non-significant) or the dorsal cortex (CTRL, 0.79 ± 0.06, total of 131 
EYFP+ cells, n=5 animals; KO, 0.72 ± 0.07, total of 226 EYFP+ cells, n=7 animals; p > 
0.05, non-significant) (Figure 32A,B,E). 
Similarly, in the white matter regions too, the population of EYFP+ cells that were 
NG2+ remained unchanged between the two experimental groups (fimbrae: CTRL, 0.43 
± 0.04, total of 310 EYFP+ cells, n=5 animals; KO, 0.35 ± 0.06, total of 493 EYFP+ 
cells, n=7 animals; p > 0.05, non-significant and corpus callosum: CTRL, 0.46 ± 0.06, 
total of 226 EYFP+ cells, n=5 animals; KO, 0.51 ± 0.08, total of 293 EYFP+ cells, n=7 
animals; p > 0.05, non-significant) (Figure 32C,D,E).  
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4 Discussion 
Oligodendroglial fate mapping studies that have relied on transgenic mice expressing 
Cre recombinase under various oligodendroglial promoters cross-bred to Cre reporter 
strains, have revealed conflicting results concerning the developmental fate of oli-
godendroglial precursor cells. These artificially generated oligodendroglial promoter-
Cre transgene constructs might not mimic endogenous gene expression. In order to 
avoid the pitfalls of conventional transgenesis such as- random insertion into the ge-
nome, ectopic expression of the transgene, transgene silencing at the inserted locus and 
potential mosaicism (Feng et al., 2000; Guo et al., 2009; Kang et al., 2010; Zhu et al., 
2011), this study employed a knock-in strategy at the 2´,3´-cyclic nucleotide 3´-
phosphodiesterase (CNP) gene locus, combined with the Cre-lox system. Mice resulting 
from the knock-in of Cre into the endogenous CNP locus were inter-bred with two Cre 
reporter lines: Z/EG and ROSA26/EYFP, to facilitate comparative lineage tracing of 
oligodendroglial precursors. 
The main findings of this study are that: (1) CNP-Cre mediated recombination in both 
CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP lines drives reporter expression in a dis-
tinct subpopulation of relatively differentiated oligodendroglial precursor cells (ex-
plained in section 4.1); (2) Extensive oligodendrogliogenesis is observed in the CNP-
Cre:Z/EG and CNP-Cre:ROSA26/EYFP mice, with EGFP and EYFP expression by all 
mature myelinating oligodendrocytes; (3) Exclusively in the CNP-Cre:ROSA26/EYFP 
line, EYFP reporter expression was observed in a small subset of astrocytes in the ven-
tral cortex, as well as in a subpopulation of neurons in the dorsal, ventral and piriform 
cortices; and (4) Further examination of embryonic reporter expression revealed that the 
highly sensitive ROSA26/EYFP Cre reporter used in the CNP-Cre:ROSA26/EYFP line, 
detects transient Cnp promoter activity-dependent Cre expression in radial glia-like 
cells, thereby explaining reporter presence in astrocytes and neurons in this line. 
As will be outlined below, I can conclude from my results that oligodendroglial precur-
sors remain committed to the oligodendroglial lineage and do not display multipotency. 
The unexpected observation of astrocytic and neuronal progeny could be attributed to 
transient oligodendroglial gene promoter activity in a neural stem cell niche. This is 
only detected by a sensitive Cre reporter; thereby indicating that choice of Cre reporters 
introduces a strong bias in fate mapping results. 
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4.1 Lineage assessment of OPCs 
As has been described in length (section 1.2.3.4), OPCs change their gene expression 
profiles upon differentiation to oligodendrocytes; they cease to express NG2 and PDG-
FRα and start the expression of mature oligodendroglial markers such as CNP, GalC 
PLP to name a few. In vivo studies employ these oligodendroglial lineage markers to 
ascertain whether OPCs display lineage plasticity and possess an astrogliogenic or neu-
rogenic potential, in addition to generating oligodendrocytes.  
Cnp promoter driven cell targeting strategies, allow the assessment of oligodendroglial 
lineage development and function in vivo, since transcription of the CNP gene begins 
during early embryonic developmental stages of the oligodendroglial lineage with an 
expression pattern similar to that of other oligodendroglial-specific markers. In addition 
to its well documented expression in the oligodendroglial lineage, CNP-Cre driven re-
porter expression in a neural stem cell niche, suggests that transient Cnp promoter activ-
ity could also be present outside of the oligodendroglial lineage (explained in section 
4.1.1). 
In the CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP lines, reporter positive cells were 
uniformly distributed throughout gray and white matter regions. At early postnatal ages 
in both experimental groups, not all NG2 cells expressed EGFP or EYFP; thus reporter 
expression was confined to a subset of OPCs (Figure 14). The CNP gene product- 
CNPase, occurs only in mature myelinating oligodendrocytes (Sprinkle, 1989). There-
fore an OPC that has started to develop towards a mature oligodendrocyte would change 
its gene expression profile to exhibit Cnp promoter activity and display reporter positiv-
ity. I term this subset of CNP-Cre expressing oligodendroglial lineage precursors as 
relatively differentiated or “late OPCs”. Cnp promoter activity in these late OPCs 
would make them distinct from the OPC population consisting of comparatively imma-
ture or “early OPCs” which perhaps have not yet made the decision to develop into 
oligodendrocytes. These early OPCs would remain unlabelled by CNP-Cre mediated 
recombination. 
Further immunolabelling experiments with markers of “mature” OPCs, immediately 
prior to differentiation to oligodendrocytes, for e.g. G-protein coupled receptor 17 
(GPR17) (Boda et al., 2011) or O1 (Baumann and Pham-Dinh, 2001) could help to as-
certain the relatively differentiated phenotype of reporter positive OPCs in this study. 
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CNP-EGFP transgenic mice have been generated in the past in order to study oligoden-
droglial lineage development. In these animals, all NG2 cells expressed the reporter, 
which is in pronounced contrast to the presence of reporter expression in a restricted 
population of OPCs in my study (Yuan et al., 2002). I attribute this discrepancy to the 
CNP-EGFP line being a transgenic mouse line in which the artificial Cnp promoter is 
used. In absence of endogenous gene regulatory elements and MicroRNA mediated 
control, ectopic expression of the CNP gene could drive reporter expression in OPCs 
that were not labelled in my study with endogenous CNP expression. Differential pat-
terns of reporter expression have also been observed in mouse models using different 
Plp promoter constructs with and without endogenous regulatory sequences (Belachew 
et al., 2001). 
In the present study with the CNP-Cre knock-in line, limited CNP-Cre driven reporter 
expression in NG2 cells can arise from the following possibilities: (1) Activity of the 
Cnp promoter in a restricted subset of NG2 cells, would result in only this subset being 
labelled by CNP-Cre mediated recombination; and (2) Extremely low Cnp promoter-
driven Cre expression levels remaining undetected by the Cre reporter and/or incom-
plete reporter target excision in a subpopulation of OPCs. Thereby, resulting in the effi-
ciency of CNP-Cre mediated recombination being below 100% in the experimental 
mouse lines.  
It can be ruled out that the efficiency of Cre recombination is not 100% in the CNP-
Cre:Z/EG and CNP-Cre:ROSA26/EYFP lines, since EGFP and EYFP labelling is pre-
sent in all oligodendroglial cells at postnatal ages examined. The proportion of reporter 
positive cells among NG2 cells was higher in the CNP-Cre:ROSA26/EYFP line as 
compare to the CNP-Cre:Z/EG line, on account of ROSA26/EYFP being a highly sensi-
tive Cre reporter which detects even low Cre expression levels (discussed in section 
4.5). But even in the CNP-Cre:ROSA26/EYFP line only ~60% of NG2 cells elicited 
reporter positivity, this argues against the possibility that absence of reporter expression 
in a subset of NG2 cells is due to low Cnp promoter driven-Cre expression levels.  
These explanations indicate a preferential CNP-Cre mediated reporter labelling in a 
subset of relatively differentiated oligodendroglial precursors that display Cnp promoter 
activity; I designate this population as “CNP-Cre expressing late OPCs”.  
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4.1.1 Oligodendrocytic promoter expression in radial glia-like cells 
A large number of reporter positive cells were detected in the CNP-Cre:ROSA26/EYFP 
line at embryonic time points (Figure 25), this is consistent with the temporal pattern of 
expression of Cnp, Pdgfra and Dm-20 transcripts at the onset of glial development. In 
situ hybridisation studies report CNP mRNA expression in a thin longitudnal zone of 
the E12.5-E14 diencephalon and spinal cord. Cnp transcripts were shown to co-localize 
in time and space with cells that express mRNA encoding Pdgfra. Transcripts encoding 
DM-20 detected at E9.5 also had a pattern of expression superimposable on the CNP 
transcript (Peyron et al., 1997; Yu et al., 1994). At E12.5 EYFP+ cells were found in the 
VZ of the ventral part of the LGE, and a few scattered cells in the MGE, with a pattern 
similar to the radial glial marker-RC2 and the pro-neural bHLH transcription factor-
Mash1, known to be expressed by radial glial cells (Casarosa et al., 1999; Yun et al., 
2002; Hartfuss et al., 2001). This strongly suggested that embryonic reporter positive 
cells observed in the CNP-Cre:ROSA26/EYFP line could represent a radial glial popu-
lation. EYFP+ cells had a typical radial glial phenotype with a spindle shaped, elon-
gated cell body and in a few cases a single process extending towards the pial surface. 
The radial glial phenotype of these cells was further confirmed BLBP immunolabelling 
(Figure 26). BLBP+/EYFP+ radial glial cells were present at the dorsal, ventral and 
lateral ventricular walls. In the muCNP-βgeo transgenic mice, β-gal activity has also 
been reported in radial glial cells; this is indicative of Cnp promoter activity in these 
cells (Chandross et al., 1999; Kurtz et al., 1994). In the present study, the radial glial 
phenotype of a subset reporter positive cells is indicative that the Cnp promoter is active 
in these neural progenitor cells of the CNS. I term these reporter positive cells as “Cnp 
promoter active neural stem cells”. 
Taking together these findings, the following inference can be drawn: apart from its 
expression in relatively differentiated or “late OPCs”, activity of the Cnp promoter also 
labels a more precursor neural stem cell pool in this study: the “Cnp promoter active 
neural stem cells”. This is confirmed from the radial glial phenotype of embryonic re-
porter positive cells. 
4.2 Extensive oligodendrogliogenesis from OPCs  
In keeping with the hypothesis that CNP-Cre mediated reporter expression is present in 
a population of “late OPCs”, EGFP and EYFP labelling was present in all mature oli-
4 Discussion 86 
godendrocytes at postnatal ages examined in both the CNP-Cre:Z/EG and CNP-
Cre:ROSA26/EYFP lines. The presence of EGFP+/EYFP+ mature oligodendrocytes 
with myelinating processes in the dorsal cortex indicates that CNP-Cre expressing 
OPCs generate oligodendrocytes in both gray and white matter regions. Radial glial 
cells expressing Cnp promoter activity-dependent EYFP reporter expression are also 
known to generate oligodendrocytes through an intermediate oligodendrocyte precursor 
stage (Kriegstein and Alvarez-Buylla, 2009). The oligodendrogliogenic potential of 
progenitor cells in which the Cnp promoter is active, exhibited in this study is in con-
junction with in vitro studies that employ the CNP-EGFP transgenic mice to show the 
generation of oligodendrocytes from CNP positive cells (Aguirre and Gallo, 2004; 
Belachew et al., 2003). Postnatal oligodendrogliogenesis from NG2 progenitors has also 
been demonstrated (Dimou et al., 2008; Guo et al., 2009; Zhu et al., 2011; Rivers et al., 
2008; Kang et al., 2010). 
An interesting finding limited to the CNP-Cre:ROSA26/EYFP mice was that in the dor-
sal cortex at P10 and to a larger extent at P30, there was a considerable population of 
reporter positive cells that did not co-label either NG2 or CC1 and exhibited a morphol-
ogy quite distinct from NG2 cells and mature oligodendrocytes. This gave rise to the 
question whether CNP-Cre expressing OPCs in the gray matter served as putative pro-
genitors to cell types that did not belong to oligodendroglial lineage.  
4.3 OPCs do not generate neurons 
Amongst the most fiercely debated questions in the field of oligodendroglial biology is 
whether OPCs serve as neuronal progenitors in the CNS. It has been shown in culture, 
that NG2 glia exposed to specific environmental signals revert to a multipotent state and 
generate neurons (Kondo and Raff, 2000). Adult human subcortical white matter cells 
isolated by Cnp2 promoter activity generated neurons in vitro and in transplanted grafts 
(Nunes et al., 2003). OPCs from transgenic CNP-EGFP mice were shown to differenti-
ate into neurons in vitro and upon transplantation into neurogenic regions of the postna-
tal brain (Belachew et al., 2003; Aguirre et al., 2004; Aguirre and Gallo, 2004). Recent 
Cre-lox fate mapping studies also suggest a neurogenic potential of OPCs (Rivers et al., 
2008; Guo et al., 2009, 2010). 
The current study presents compelling evidence of large scale neurogenesis from Cnp 
promoter active neural stem cells in the dorsal, ventral and piriform cortices (Figure 20). 
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Reporter positive neurons were classified on the basis of immunoreactivity for NeuN, a 
ubiquitous mature neuronal marker (Mullen et al., 1992). In some cases, reporter posi-
tive cells had the appearance of projection neurons, with large cell bodies and long ax-
ons. Importantly, reporter positive neurons were observed exclusively in the CNP-
Cre:ROSA26/EYFP line, where EYFP labelling due to Cnp promoter activity extends 
beyond oligodendroglial lineage precursors to a neural stem cell niche. 
4.3.1 Radial glia-like cells act as the neurogenic pool 
A considerable population of reporter positive radial glial cells identified by morphol-
ogy and BLBP immunolabellings were observed in the E16 CNP-Cre: ROSA26/EYFP 
dorso-lateral and ventral ventricular zone, subventricular zone and cortex (Figure 26).  
Just prior to neurogenesis, neuroepithelial cells generate radial glia at E9-E10 
(Frederiksen and McKay, 1988). It has been shown that radial glia of the dorsal telen-
cephalon (Malatesta et al., 2003) and possibly of all regions, including the ventral fore-
brain (Anthony et al., 2004; Noctor et al., 2002), pass through a neurogenic phase and 
are the principal neuronal precursors throughout the CNS.  
I speculate in this study that radial glial cells in the ventral and dorsal ventricular zone 
transiently express the Cnp gene, which results in reporter expression in radial glial 
cells and their progeny. It would be relatively safe to assume that this small subset of 
Cnp promoter active radial glial cells, serves as a source of reporter positive neurons 
observed in this study; as reporter expression was not observed in neurons in the CNP-
Cre:Z/EG line where radial-glia like cells were not EGFP labelled. Also present at the 
lateral ventricular wall at E16 were EYFP labelled cells that were neither radial-glia like 
cells nor NG2 cells, it can be assumed that these cells were basal progenitor cells known 
to be the progeny of radial glial cells and serving as neuronal precursors (Malatesta et 
al., 2008). 
VZ and SVZ progenitors produce neurons destined for different cortical layers from 
E11.5 to E17.5 in the mouse (Angevine and Sidman, 1961; Caviness and 
Takahashi,1995; Rakic, 1974). To verify if the embryonic Cnp promoter active neural 
stem cells observed in CNP-Cre:ROSA26/EYFP mice constituted the neurogenic pool; 
BrdU was administered at E12.5 in an attempt to target the early wave of neurogenesis. 
A large fraction of EYFP+ neurons in the ventral and piriform cortices co-labelled BrdU 
after a long ~40 day chase; suggesting that they were generated embryonically from 
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Cnp promoter active radial glia-like cells (Figure 23). No reporter positive NG2 cells 
co-labelled BrdU at P30 after a pulse at E12.5 (Figure 24). NG2 cells are generated 
from progenitor cells that would have been labelled by the E12.5 BrdU injection; it was 
therefore surprising that no BrdU positivity was found in NG2 cells. It can be specu-
lated that the BrdU label is lost due to repeated cycles of divisions of the NG2 cell, 
which is an actively mitotic postnatal cell population. It also cannot be ruled out that an 
NG2 cell that had incorporated BrdU label from its precursor cell upon E12.5 BrdU 
administration, lost the BrdU label on subsequent divisions and became quiescent post-
natally, did trans-differentiate into a neuron. This mode of neurogenesis via trans-
differentiation from a quiescent postnatal NG2 cell would ensure the absence of BrdU 
labelling in it upon postnatal BrdU administration. 
Some of the earliest born neurons that originate in the ventral telencephalon from 
E12.5-E14, migrate tangentially to populate the dorsal cortex (Anderson et al., 2001). 
Radial glial progenitors of the ventral forebrain generate GABAergic inhibitory neu-
rons, including basal ganglia neurons as well olfactory bulb interneurons, which popu-
late the ventral and piriform cortices respectively; while dorsal forebrain progenitors 
give rise to glutamatergic neurons at the dorsal cortex (Guillemot, 2005; Kriegstein and 
Götz, 2003). The ventral forebrain regions where EYFP+BrdU+ neurons were observed 
(Figure 23) are the anterior amygdaloid area (AA) and anterior amygdaloid nucleus 
(ACo), where it has been shown that peak neurogenesis occurs from E12.5-E14 (Bayer, 
1980). The largest part of the primary olfactory cortex is made up by the piriform cor-
tex, which constitutes the third step in the pathway of odour information processing 
after the olfactory epithelium and bulb (Suzuki and Bekkers, 2007). A large majority of 
layer II cells are born at E12 than at E14 or E16 and these E12 born cells differentiate 
into pyramidal neurons in this trilaminar cortex (Sarma et al., 2011; Bayer, 1986). Thus, 
peak neurogenesis in the ventral and piriform cortex matches perfectly with the E12.5 
BrdU administration strategy used in this study; thereby targeting majority of EYFP+ 
neurons of these regions. Almost no BrdU labelled neurons were found in the layer II 
dorsal cortex under examination, this is most likely expected as neurons of the cortical 
plate (layer II to VI) are generated between E15-E16 (Bayer and Altman, 1990): a time 
point not targeted by E12.5 BrdU administration, thus resulting in no labelling of late 
neuronal progenitors. This was also in conjunction with parallel experiments in wild 
type mice, where E16 BrdU injections primarily labelled these later born neurons in the 
dorsal cortex (Figure 22). As has been already mentioned, the cortical interneurons gen-
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erated in the ventral forebrain migrate tangentially to the dorsal cortex. Therefore, the 
very small subset of BrdU labelled reporter positive neurons (0.025 ± 0.008) observed 
in the dorsal cortex upon E12.5 BrdU administration, could possibly account for those 
neurons that have migrated from the ventral telencephalon.  
Postnatal BrdU labelling studies reveal that NG2 cells constitute ~75% of the BrdU 
positive cells in gray matter regions (Dawson, 2003); thus the absence of any BrdU  
label in EYFP+ neurons upon postnatal BrdU administration in my study indicates that 
these are not generated atleast from the major postnatally cycling cell population i.e. 
NG2+ OPCs. Since no BrdU+EYFP+ neurons were found after four consecutive post-
natal days of BrdU labelling, followed by a ~20 day chase; this argues against the gen-
eration of the observed reporter neurons from postnatal CNP-Cre expressing OPCs. On 
the other hand, it can be imagined that postnatally generated neurons were not BrdU 
labelled in this particular study because: (1) BrdU was pulsed from P10 to P13, perhaps 
not targeting the time window for postnatal neurogenesis; (2) Alternatively, it can also 
be that a late postnatal trickle of neurogenesis occurs by trans-differentiation of postmi-
totic CNP-Cre expressing OPCs; and (3) Cnp promoter activity-dependent labelling in 
adult neural stem cells of the SVZ could be another source of neurons observed only in 
the CNP-Cre:ROSA26/EYFP line. 
If indeed transdifferentiation of CNP-Cre expressing OPCs led to generation of neurons, 
one would expect to observe reporter positive neurons in the CNP-Cre:Z/EG line as 
well. However, no reporter positive neurons were observed in the CNP-Cre:Z/EG line, 
where reporter expression was restricted to cells of the oligodendroglial lineage and did 
not extend into the neural stem cell niche. Therefore, together with the observation that 
there was no increase in the number of EYFP+ neurons with age (section 3.3.3.1), post-
natal neurogenesis from CNP-Cre expressing OPCs seems improbable. These results 
demonstrate that embryonic Cnp promoter active radial glial precursors and not CNP-
Cre expressing OPCs generate neurons. Additional postnatal BrdU pulse chase experi-
ments would need to be combined with littermate control experiments verifying distri-
bution of EYFP+ neurons with age, in order to address the question of postnatal neuro-
genesis from adult SVZ stem cells. 
Postnatal neurogenesis has been reported from OPCs using inducible Cre expression 
under the Plp and Pdgfra promoters (Guo et al., 2009; Rivers et al., 2008). While Guo 
et al. (2009) show neurogenesis from early postnatal Plp promoter expressing-
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progenitors, Rivers et al. (2008) failed to demonstrate BrdU labelling in their reporter 
positive neurons and hence, concluded that these neurons were the result of direct trans-
differentiation from post-mitotic NG2 cells. It can be argued that with their transgenic 
constructs these studies labelled neonatal as well as adult SVZ neural stem cells which 
resulted in the observation of reporter positive neurons. 
Neurogenesis was not detected in studies using Cre expression under the Pdgfra (Kang 
et al., 2010), Cspg4 promoters (Zhu et al., 2008, 2011) and Olig2 promoters (Dimou et 
al., 2008). However using another inducible Olig2creERTM line, Ono et al. (2008) dem-
onstrated extensive neurogenesis in the telencephalon by E12.5 Olig2+ precursors. It is 
worth mentioning that Kang et al. (2010) and Dimou et al. (2008) did observe a few 
reporter positive neurons in gray matter regions, which they dismissed as ectopic Cre-
driven reporter expression in neurons themselves. The presence of BrdU labelling in 
reporter positive neurons in this study, argues against reporter positivity due to ectopic 
Cre expression or transient CNP expression by neurons; but rather provides direct evi-
dence of neurogenesis from proliferating Cnp promoter active embryonic precursors. 
However, another possibility cannot be ruled out: neurons were BrdU labelled since 
they were generated from EYFP negative neuronal precursors targeted by the E12.5 
BrdU pulse, and subsequently became EYFP positive due to ectopic Cre expression. 
Having observed reporter expression in embryonic neural stem cells in the CNP-Cre: 
ROSA26/EYFP line, an approach with inducible Cre expression under the NG2 pro-
moter was adopted to specifically answer if oligodendroglial precursors had a neuronal 
fate. 
Extensive neurogenesis was observed in adult P30 NG2creERTMBAC:ROSA26/EYFP 
mice induced with Cre at late embryonic ages. Reporter positive neurons were observed 
both in the neocortex and palaeocortex. The radial glial phenotype of embryonic re-
porter positive cells, lends support to the speculation made in this study, as well as by 
Richardson et al. (2011), that the NG2 promoter and other oligodendroglial lineage 
gene, might be transiently switched on in these neural stem cell types, at extremely low 
levels.Thus, oligodendrocyte promoter-Cre lines cross-bred with the sensitive Cre re-
porter: ROSA26/EYFP, will ensure that these low oligodendrocyte promoter driven Cre 
expression levels are detected, leading to reporter expression in these cell types. EYFP 
reporter expression in neural stem cells would also explain the presence of reporter 
positivity in neurons. 
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A similar study by Zhu et al. (2011), using NG2creERTMBAC transgenesis with the 
Z/EG Cre reporter failed to report any neurogenesis. As opposed to reporter expression 
in radial glia-like cells at embryonic time points in this study, Zhu et al. (2011) observed 
that all EGFP+ cells at E19.5 were NG2+. The discrepancies in these results can be due 
to two separate Cre reporter lines used; re-emphasizing the point that low and transient 
NG2 promoter expression in neural stem cells can be detected only by the RO-
SA26/EYFP Cre reporter used in this study. “Leaky” Cre expression in this double 
transgenic line can also be ruled out, since no reporter positivity was observed in a se-
ries of frontal sections through the dorsal, ventral and piriform cortices of control 
NG2creERTMBAC:ROSA26/EYFP mice at ~P30 that had not been administered with 
Tamoxifen prior to analysis. The absence of reporter positivity in neurons upon postna-
tal Cre induction also confirms that only embryonic reporter positive radial glia-like 
cells and not NG2 cells serve as progenitors of the observed neurons. 
4.4 Astrocyte generation from radial glia-like cells rather than 
from OPCs 
In the early 1990’s, in vivo studies reporting the absence of GFAP+/NG2+ cells (Skoff, 
1990; Fulton et al., 1992) alongwith lack of evidence of astrocytic generation from 
transplanted OPCs (Groves et al., 1993), led many investigators to conclude that the 
observation by Raff et al. (1983) of the astrogliogenic potential of OPCs was merely 
a culture artefact (Noble et al., 2005). Almost more than a decade later, direct in vivo 
fate mapping studies have lend support to the observations of Raff et al. (1983) 
regarding astrocytic generation from OPCs in the normal (Zhu et al., 2008a, 2008b, 
2011; Guo et al., 2009) and compromised CNS (Tripathi et al., 2010; Zawadzka et al., 
2010).  This study demonstrates EYFP reporter expression by astrocytes exclusively in the 
CNP-Cre:ROSA26/EYFP line. Reporter positive cells with a highly branched, fine ar-
borisation of bushy processes reminiscent of protoplasmic astrocytes (Bushong et al., 
2004), were most prevalent in the ventral forebrain regions at both early and late postna-
tal ages under examination (Figure 19). While most of the reporter cells that were char-
acterised as astrocytes displayed GFAP immunoreactivity, there were a few GFAP neg-
ative cells classified as being astrocytes based on their highly ramified and complex 
morphology. The ventral forebrain remains the predominant region where reporter posi-
tive astrocytes were observed. Reporter positive/GFAP positive cells in the dorsal cor-
tex were not an infrequent occurrence, alongwith the presence of reporter positive fi-
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brous astrocytes in the white matter regions of corpus callosum and fimbrae. Reporter 
positive astrocytes appeared to increase slightly from P6 to P30 and occurred mostly in 
cohorts of doublets or triplets, indicative of local proliferation of newly generated astro-
cytes. 
The time point of astrocytic generation from Cnp promoter active progenitor cells can-
not be ascertained with the current set of experiments where Cre is expressed constitu-
tively under the Cnp promoter. However, I suggest that the source of astrocytes ob-
served in my study could be radial glial cells in which the Cnp promoter as well as other 
oligodendroglial promoters are active, and not CNP-Cre expressing late OPCs because: 
(1) Reporter positive astrocytes were only observed in the CNP-Cre:ROSA26/EYFP 
line in which Cnp promoter active radial glia-like cells at the dorso-lateral and ventral 
ventricular walls were EYFP labelled, and not in the CNP-Cre:Z/EG line in which only 
CNP-Cre expressing oligodendroglial precursors were labelled. If astrocytes were gen-
erated from oligodendroglial precursors then they should have been EGFP labelled also 
in the CNP-Cre:Z/EG line; and (2) In their experiments with the 
NG2creERTMBAC:Z/EG line, reporter labelled astrocytes were only observed upon em-
bryonic Tamoxifen induction which also labelled radial-glia like cells, but not when 
only oligodendroglial lineage precursors were labelled by postnatal TMX induction 
(Zhu et al., 2011). 
Radial glia and SVZ neural stem cells are known to generate astrocytes in gray and 
white matter telencephalic regions (Voigt, 1989; Mission et al., 1991; Levison et al., 
1993; Malatesta et al., 2000). Therefore, I hypothesize that these embryonic Cnp pro-
moter active neural stem cell niche served as the astrogliogenic pool in the present 
study.  
However, it is important to note that within the scope of experiments performed in this 
study, it cannot be ruled out that astrocytes were reporter positive due to the fact that 
they themselves expressed Cre ectopically. 
Zhu et al. (2011) suggest that there exist separate subpopulations of OPCs that are as-
trogliogenic and oligogenic in the developing brain. Therefore, in their experiments 
where Cre was induced at E16.5 with TMX injections to NG2creERTM:Z/EG animals, 
this embryonic “astrogliogenic pool of OPCs” led to reporter positive astrocytes in the 
ventral forebrain. However, with postnatal (P2 and P60) TMX injections, no EGFP+ 
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astrocytes were observed in the forebrain. This suggests that a subset of OPCs only at 
late embryonic ages generate ventral forebrain astrocytes. 
 In studies using artificially generated Cnp promoter to drive EGFP expression- CNP-
EGFP transgenic line (Yuan et al., 2002), it has been shown that fluorescence-activated 
cell sorting (FACS) sorted EGFP+ cells displaying CNP gene activity were multipotent 
and gave rise to astrocytes in vitro (Nunes et al., 2003; Belachew et al., 2003). It can be 
assumed that the artificial Cnp promoter used in these studies could drive reporter posi-
tivity in a neural stem cell niche. Studies using BAC transgenic Pdgfra-creERTM mice 
which were Cre induced at P45 (Rivers et al., 2008) and P30 (Kang et al., 2010), failed 
to report positivity in astrocytes. Another study using Olig2creERTM mice (Dimou et al., 
2008) Cre induced at 2.5 month and 6 month of age, has also challenged the astroglio-
genic potential of OPCs. The discrepancies in these results are perhaps because these 
studies investigated the progeny of postnatal OPCs and do not label embryonic OPCs or 
transient oligodendrocyte promoter-expressing radial glial cells. 
4.5 Differences between Cre reporter lines: contribution 
towards a bias in fate mapping results 
Different lineages of progenitors labelled by the CNP-Cre knock-in approach are ob-
served by employing two separate Cre reporter lines used (see Table 2).  
 
Table 2. Comparative lineage of precursor cells labelled by CNP-Cre mediated recombination 
with the Z/EG and ROSA26/EYFP Cre reporters. 
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Oligodendrocytes are the only reporter positive cells detected throughout the gray and 
white matter regions of CNP-Cre:Z/EG mice. In absolute contrast, with the inter-
breeding strategy involving ROSA26/EYFP Cre reporter, in addition to oligodendro-
cytes and a small subset of astrocytes, large number of neurons appear reporter positive. 
It is well documented that different Cre reporter lines possess varying recombination 
efficacies (Richardson et al., 2011), which might contribute extensively in influencing 
the outcome of lineage tracing results. The present study is the first of its kind that com-
pares and integrates data obtained by using two separate Cre reporter lines in investigat-
ing the fate of “late OPCs”; thereby providing a clearer understanding of fate mapping 
data. 
It is noteworthy, that of the two mouse lines: CNP-Cre:Z/EG and CNP-
Cre:ROSA26/EYFP, reporter positive cell types, namely embryonic radial glial cells, 
astrocytes and neurons were primarily detected in the latter line which uses the RO-
SA26/EYFP Cre reporter (Srinivas et al., 2001). Several reasons can be attributed to this 
differential fate observed between the experimental groups using the two separate Cre 
reporter lines: (1) Different promoter constructs were used to drive reporter transgene 
expression, while the Z/EG line uses the strong pCAGGS promoter, EYFP expression 
in the ROSA26/EYFP line is achieved by targeting the ubiquitously expressed ROSA26 
locus. It cannot be ruled out that this could lead to differences in the pattern and levels 
of reporter transgene expression. Due to different promoter constructs, it could also be 
that one or the other reporter transgene is preferentially expressed in certain cell types, 
thereby introducing an unwanted bias in cell type specificity. This can be ruled out to a 
certain extent in double reporters like the Z/EG line used in this study, wherein overlap-
ping expression patterns of both reporters have been observed (Novak et al., 2000); and 
(2) The ROSA26/EYFP line (Srinivas et al., 2001) is considered a more sensitive Cre 
reporter which can detect very low Cre expression levels, which would otherwise re-
main undetected by the Z/EG line that recombines less efficiently (Novak et al., 2000). 
For instance, using the NG2creERTM and Pdgfra-creERTM lines, 30 fold and more than 2 
fold higher Cre recombination efficacies were achieved when the Z/EG Cre reporter 
was replaced by the ROSA26/EYFP (Zhu et al., 2011; Kang et al., 2010). It has been 
suggested that the stoichiometric threshold for Cre expression or the minimal concentra-
tion of Cre required in the cell nucleus, below which minimal recombination occurs, is 
lower for a good recombiner (Richardson et al., 2011). Thus, low and transient expres-
sion levels of Cnp promoter-driven Cre in embryonic radial glial cells is only “picked 
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up” by the sensitive ROSA26/EYFP Cre reporter used in the CNP-Cre:ROSA26/EYFP 
line and remains undetected in the CNP-Cre:Z/EG line. In addition, location of the re-
porter transgene cassette and the distance between the loxP sites could also be the fac-
tors influencing different Cre recombination efficiencies.  
The detection of CNP-Cre driven reporter expression in radial glia-like cells, which 
serve as the source of the observed reporter positive neurons, make the CNP-
Cre:ROSA26/EYFP line unsuitable for studying purely oligodendroglial lineage devel-
opment. On the other hand, the CNP-Cre :Z/EG, results in the detection of reporter posi-
tivity only in cells of the oligodendroglial lineage. Therefore, the choice of Cre reporter 
results in differences in the cell populations being labelled and this is the reason for a 
stark contrast in the lineage of precursor cells labelled by CNP-Cre mediated recombi-
nation. 
4.6 Developmental regulation of CNP expression: a possible 
role of MicroRNAs  
Key players of the posttranscriptional silencing machinery- MicroRNAs (miRNAs) are 
known to be enriched in oligodendroglial lineage cells and have been implicated as crit-
ical regulators of oligodendrocyte development and myelination. It has been shown that 
miR-219, miR-338 and Dicer1 are required for normal oligodendrocyte differentiation 
and developmental myelination (Dugas et al., 2010; Zhao et al., 2010). Conditional Dic-
er deletion in oligodendroglial lineage cells using the CNP-Cre mice has also been 
shown to effect oligodendrocyte cell number (Budde et al., 2010). 
In P10 CNP-Cre:Z/EG and CNP-Cre:ROSA26/EYFP mice, reporter positivity was pre-
sent in a large subset of OPCs. This indicates that in these subsets of reporter positive 
NG2 cells, Cre recombination under the Cnp promoter had taken place; implying that 
the CNP gene was actively transcribed in these cell populations. However, CNP 
immmunolabelling revealed that none of the reporter positive NG2 cells in either gray 
or white matter expressed the CNP protein (Figure 27). This is consistent with the ap-
pearance of Cnp transcripts in the CNS as early as E12.5 (Peyron et al., 1997), and that 
the CNP protein is seen only much later to be expressed by differentiating oligodendro-
cytes (Baumann and Pham-Dinh, 2001).This regulation in the timing of expression of 
the Cnp mRNA and protein hints towards a possible role of miRNAs. The absence of 
CNP protein in OPCs compared with the broad distribution of its message in these cell 
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types supports a posttranscriptional control; such that interaction of an miRNA with the 
CNP mRNA blocks protein translation, and that this inhibitory effect is only removed 
later in the developmental lineage of the OPC, leading to CNP protein expression in the 
ensuing mature stages. Similar to the developmental pattern of expression of the CNP 
gene, PLP mRNA is expressed embryonically, whereas the protein is expressed only 
much later by myelinating oligodendrocytes postnatally (Baumann and Pham-Dinh, 
2001). miR-20a has been reported to regulate PLP gene expression through its 3’UTR 
(Wang and Cambi, 2012). Therefore, it can be imagined that regulation of CNP expres-
sion action of miRNA’s, could play a defining role in the early stages of oligodendro-
glial development. 
4.7 AMPA receptor subunit composition in OPCs influences 
proliferation 
Chemical synaptic transmission is not used exclusively for communication between 
neurons. A wealth of studies in the recent decade has shown that NG2 glia form direct 
synaptic contacts with both glutamatergic and GABAergic neurons (Paukert and 
Bergles, 2006; Kukley et al., 2007; Ziskin et al., 2007). The finding that NG2 cells re-
ceive both excitatory and inhibitory synaptic input raised the possibility that neuron-glia 
signalling at the synapse could influence development and cellular properties of OPCs. 
A number of studies have previously shown that electrical activity of the axon controls 
OPC proliferation and myelinogenesis (Gyllensten and Malmfors, 1963; Barres and 
Raff, 1993; Demerens et al., 1996). Furthermore, in vitro experiments show that vesicu-
larly released glutamate influences initial events in myelination (Wake et al., 2011). It is 
important however to note that these studies modify axonal release to investigate its role 
in oligodendroglial development, and this could also regulate neuron-neuron interac-
tions in addition to influencing neuron-OPC signalling. On the other hand, in my study I 
concentrate on the detection site of the neuron-OPC synapse and modify the AMPA 
receptor subunit- GluRB on the NG2 cell, to ascertain its effect on OPC behaviour and 
physiology. 
The GluRB subunit was genetically ablated only in OPCs by an inducible Cre-lox based 
experimental approach; and subsequent inter-breeding with a Cre reporter line ensured 
EYFP labelling of targeted OPCs. 0.5 mg Tamoxifen was administered to GluRB KO 
and GluRB CTRL experimental groups at P5-P10 for 1 or 3 days and ~2 weeks after the 
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last TMX injection, animals were given 300 mg/kg BrdU. In the GluRB knockout 
group, NG2 cells that had lost the GluRB subunit were EYFP labelled, while EYFP 
labelled NG2 cells in the GluRB control group still possessed the GluRB subunit. The 
absolute number of reporter positive cells remained unchanged between the control and 
experimental groups; however, the proportion reporter positive cells that were BrdU+ 
cells was significantly reduced in the GluRB knockout group (Figure 31). A reduction 
in proliferation of EYFP labelled cells, which are presumably NG2 cells as they repre-
sent the major cycling cell population in the postnatal brain (Dawson, 2003; Psachoulia 
et al., 2009), while keeping the absolute numbers same, seems confusing. If NG2 cells 
proliferated less upon GluRB deletion, reduced number of EYFP+ cells should have 
been observed in the GluRB KO group, unless GluRB ablation changed NG2Cre ex-
pression in the KO group. This discrepancy with respect to the observed absolute num-
ber of EYFP+ cells can perhaps be attributed to variances due to the Tamoxifen induc-
tion protocols, since the TMX injections could greatly influence Cre-mediated EYFP 
positive cell counts. Therefore, it cannot be said with certainity that the absolute number 
of EYFP+ cells remained unchanged between the two experimental groups. 
The GluRB subunit governs the receptors Ca++ permeability, with its presence rendering 
the receptor Ca++ impermeable and its absence leading to an increased Ca++ influx into 
the cell. Keeping this in mind, the present study indicates that removing the GluRB 
subunit from the OPC, leading to an increased Ca++ influx into the cell in response to 
endogenous neuronal activity-mediated glutamate release; in turn inhibits OPC prolif-
eration. Inhibition of proliferation could initiate the differentiation of an OPC towards 
the mature oligodendrocyte stage. Kukley et al. (2010) have shown that synaptic input is 
lost upon differentiation of the OPC towards the mature oligodendroglial state; therefore 
it can be speculated that an increased Ca++ influx upon GluRB removal could lead to a 
downregulation of synaptic input onto the OPC. Inhibition of OPC proliferation due to 
GluRB removal-mediated Ca++ influx seems consistent when extended to an unpub-
lished observation by our own group where electrical stimulation is in the corpus callo-
sum has been shown to decrease the total number of proliferating cells. It has also pre-
viously been demonstrated using cortical OPC cultures, that non-NMDA glutamate re-
ceptor agonists inhibit cell proliferation (Gallo et al., 1996).  
As has been mentioned above, a decrease in the rate of OPC proliferation upon GluRB 
removal, could perhaps give rise to the scenario that OPCs in the GluRB knockouts un-
dergo differentiation to generate mature oligodendrocytes. It can be imagined that cell 
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cycle arrest which would permit the OPC to undertake the differentiation pathway, 
would also lead to a decrease in the incorporation of BrdU, as observed in the GluRB 
knockouts. Cell cycle withdrawal by cyclin-dependent kinase (CDK) inhibitor has been 
shown to facilitate differentiation of OPCs (Casaccia-Bonnefil et al., 1997).  
To verify if glutamatergic signalling via the GluRB subunit influences myelination and 
differentiation of OPCs, the fraction of EYFP+ cells that were NG2 cells was deter-
mined. For this P10 to P20 animals of the GluRB KO group and GluRB CTRL group 
were given 0.5 mg Tamoxifen (single i.p injection for 3 or 6 days) and analysed ~10 
days after the last TMX injection. The fraction of reporter positive cells that were NG2+ 
remained unchanged between the two experimental groups; this would suggest that al-
tering the glutamatergic input by GluRB deletion has no effect on myelination (Figure 
32). However, it must be remembered that the read out of differentiation in this study 
was the fraction of NG2 cells among EYFP+ cells and the population of mature oli-
godendrocytes among reporter positive cells was not calculated. NG2 cells could have 
undergone asymmetric division, thus keeping the number of NG2+EYFP+ cells same. 
Further experiments determining the fraction of mature CC1+ oligodendocytes among 
reporter positive cells and PLP immunolabellings identifying myelin sheaths, would 
need to be performed to examine the effect of GluRB subunit on differentiation and 
myelination. 
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5 Summary 
In this study, I employ a mouse line in which Cre is knocked-in for the 2’,3’ -cyclic 
nucleotide 3’ –phosphodiesterase (CNP) gene and compare the fates of CNP-Cre ex-
pressing OPCs between two Cre reporters: Z/EG and ROSA26/EYFP. CNPase is found 
only in mature oligodendrocytes; therefore a subpopulation of “late” or relatively differ-
entiated OPCs which have presumably made the decision to differentiate into oligoden-
drocytes are labelled with this experimental strategy.  
In the first section of this study, I present evidence of extensive oligodendrogliogenesis 
from CNP-Cre expressing OPCs in both experimental lines. I also show a small subset 
of reporter positive astrocytes and extensive neurogenesis in discrete regions of the 
CNP-Cre:ROSA26/EYFP line: ~12% of all EYFP+ cells in the ventral cortex represent 
an astrocytic phenotype with GFAP positivity and 55-70% reporter positive cells in the 
dorsal, ventral and piriform cortices are NeuN positive neurons. In striking contrast, no 
EGFP positive astrocytes or neurons are observed in the CNP-Cre:Z/EG line.  
In the second section I report Cnp promoter activity-dependent reporter labelling in em-
bryonic radial-glia (RG) like cells which are known to display multipotency. I suggest 
that OPCs remain committed to an oligodendroglial fate and do not display lineage plas-
ticity; while oligodendroglial genes are switched on transiently in RG-like cells at ex-
tremely low levels, only to be detected by sensitive Cre reporters. I thereby show that 
fate mapping studies can be strongly biased by the choice of Cre reporter strains, result-
ing in stark differences in the progeny of oligodendroglial precursors as observed in this 
study. 
The last part of my thesis, is devouted to elucidating the functional role of the GluRB 
AMPA receptor subunit in influencing OPC physiology, by availing the GluRB floxed 
NG2creERTM:GluR-B2lox/2lox:ROSA26/EYFP mouse line. I demonstrate that removing 
the GluRB subunit from the OPC leads to a reduction in OPC proliferation in white 
matter regions. AMPA receptors are the principal mediators of glutamatergic signalling 
at the neuron-OPC synapse, and an insight into their effect on OPC development, as 
presented in this study, will further enhance our understanding of neuron-OPC cross-
talk. 
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